<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.0//EN" "http://www.w3.org/TR/2001/REC-SVG-20010904/DTD/svg10.dtd">
<svg width="2400" height="2400" xmlns="http://www.w3.org/2000/svg" style="background-color:black">
<circle cx="1200" cy="1200" r="1052" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1028" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1026" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="175" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="173" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="161" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<text font-size="4.0em" x="50" y="60" fill="white">SARS-CoV-2 mutations 2020 timemap</text>
<text font-size="2.8em" x="50" y="105" fill="white">Genbank MN908947 vs 13,037 GISAID genomes</text>
<line x1="1200" y1="83.1314031180401" x2="1200" y2="133.13140311804" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1176" y="73.1314031180401" fill="white">Winter</text>
<line x1="2267" y1="1200" x2="2317" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="2267" y="1245" fill="white">Spring</text>
<line x1="1200" y1="2267" x2="1200" y2="2317" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1045" y="2352" fill="white">Summer</text>
<line x1="133" y1="1200" x2="73" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="59" y="1185" fill="white">Fall</text>
<g>	<title>orf1ab gene (21500-21555)</title>
	<line x1="1208" y1="1039" x2="1208" y2="1027" style="stroke:grey;stroke-width:8" />
</g><g>	<title>S gene (21563-25384)</title>
	<line x1="1208" y1="1025" x2="1208" y2="174" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>ORF3a gene (25393-25500)</title>
	<line x1="1208" y1="172" x2="1208" y2="148" style="stroke:grey;stroke-width:8" />
</g><line x1="1200" y1="148.13140311804" x2="1200" y2="1039" style="stroke:white;stroke-width:3" />
<line x1="1204" y1="148.13140311804" x2="1210" y2="148.13140311804" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="148.13140311804" x2="1215" y2="123.13140311804" style="stroke:white;stroke-width:2" />
<line x1="1204" y1="1039" x2="1210" y2="1039" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="1039" x2="1215" y2="1064" style="stroke:white;stroke-width:2" />
<text font-size="2.0em" x="1215" y="123.13140311804" fill="white">25.5 kb</text>
<text font-size="2.0em" x="1215" y="1084" fill="white">21.5 kb</text>
<text font-size="2.5em" x="110" y="175" fill="white">Top countries</text>
<circle cx="60" cy="205" r="8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="215" fill="white">Australia</text>
<circle cx="60" cy="235" r="8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="245" fill="white">New Zealand</text>
<circle cx="60" cy="265" r="8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="275" fill="white">Papua New Guinea</text>
<circle cx="60" cy="295" r="8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="305" fill="white">Guam</text>
<circle cx="60.0" cy="350.0" r="1.2" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="100.0" cy="350.0" r="4.2" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="140.0" cy="350.0" r="8.0" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<text font-size="2.0em" x="50" y="395" fill="white">1      10        100% daily</text>
<text font-size="2.0em" x="50" y="425" fill="white">sample fraction</text>
<g>
	<title>2020-01-24 Australia: 3 samples</title>
	<line x1="1208.1" y1="1181.7" x2="1209.2" y2="1179.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-01-25 Australia: 3 samples</title>
	<line x1="1208.5" y1="1181.9" x2="1209.6" y2="1179.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-01-30 Australia: 8 samples</title>
	<line x1="1210.0" y1="1182.7" x2="1212.1" y2="1179.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-05 Australia: 2 samples</title>
	<line x1="1211.8" y1="1183.8" x2="1213.0" y2="1182.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-22 Australia: 2 samples</title>
	<line x1="1216.0" y1="1188.0" x2="1217.7" y2="1186.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-28 Australia: 6 samples</title>
	<line x1="1217.1" y1="1189.7" x2="1220.4" y2="1187.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-02-28  G25323T  Australia=3 [50.0%]  surface glycoprotein, C1254F</title>
	<circle cx="2068.2" cy="678.3" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-02-29 Australia: 3 samples</title>
	<line x1="1217.3" y1="1190.0" x2="1219.7" y2="1188.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-02 Australia: 3 samples</title>
	<line x1="1217.7" y1="1190.6" x2="1220.1" y2="1189.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-03 Australia: 6 samples</title>
	<line x1="1217.8" y1="1190.9" x2="1221.2" y2="1189.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-04 Australia: 9 samples</title>
	<line x1="1218.0" y1="1191.2" x2="1222.0" y2="1189.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-05 Australia: 4 samples</title>
	<line x1="1218.1" y1="1191.5" x2="1221.0" y2="1190.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-06 Australia: 6 samples</title>
	<line x1="1218.3" y1="1191.9" x2="1221.7" y2="1190.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-06  A23403G  Australia=2 [33.3%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="961.9" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-07 Australia: 4 samples</title>
	<line x1="1218.4" y1="1192.2" x2="1221.3" y2="1191.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-08 Australia: 8 samples</title>
	<line x1="1218.5" y1="1192.5" x2="1222.5" y2="1190.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-08  A23403G  Australia=2 [25.0%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="980.7" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-09 Australia: 11 samples</title>
	<line x1="1218.7" y1="1192.8" x2="1223.2" y2="1191.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-09  A23403G  Australia=3 [27.3%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="990.2" r="5.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-10 Australia: 26 samples</title>
	<line x1="1218.8" y1="1193.2" x2="1224.8" y2="1191.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-10  A23403G  Australia=4 [15.4%]  surface glycoprotein, D614G</title>
	<circle cx="1750.0" cy="999.8" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11 Australia: 24 samples</title>
	<line x1="1218.9" y1="1193.5" x2="1224.9" y2="1191.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-11 New Zealand: 3 samples</title>
	<line x1="1224.9" y1="1191.4" x2="1227.4" y2="1190.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-11  A23403G  Australia=9 [37.5%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1009.4" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12 Australia: 17 samples</title>
	<line x1="1219.0" y1="1193.8" x2="1224.4" y2="1192.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-12  A23403G  Australia=8 [47.1%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1019.1" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13 Australia: 20 samples</title>
	<line x1="1219.1" y1="1194.2" x2="1224.8" y2="1192.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-13  A23403G  Australia=8 [40.0%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1028.9" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13  G25340A  Australia=2 [10.0%]  surface glycoprotein, D1260N</title>
	<circle cx="2172.3" cy="902.7" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-14 Australia: 24 samples</title>
	<line x1="1219.2" y1="1194.5" x2="1225.3" y2="1192.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-14  A23403G  Australia=7 [29.2%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1038.7" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-15 Australia: 23 samples</title>
	<line x1="1219.3" y1="1194.8" x2="1225.3" y2="1193.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15 New Zealand: 3 samples</title>
	<line x1="1225.3" y1="1193.2" x2="1227.9" y2="1192.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15  A23403G  Australia=9 [39.1%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1048.5" r="6.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16 Australia: 37 samples</title>
	<line x1="1219.4" y1="1195.2" x2="1226.3" y2="1193.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16 New Zealand: 5 samples</title>
	<line x1="1226.3" y1="1193.4" x2="1229.7" y2="1192.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16  A23403G  New Zealand=2 [40.0%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="6.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  A23403G  New Zealand=2 [40.0%] Australia=13 [35.1%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17 Australia: 43 samples</title>
	<line x1="1219.5" y1="1195.5" x2="1226.7" y2="1193.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-17 New Zealand: 7 samples</title>
	<line x1="1226.7" y1="1193.8" x2="1230.7" y2="1192.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-17  C22224T  Australia=2 [4.7%]  surface glycoprotein, S221L</title>
	<circle cx="1514.4" cy="1127.4" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  A23403G  Australia=20 [46.5%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1068.3" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  A23403G  New Zealand=2 [28.6%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1068.3" r="5.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18 Australia: 55 samples</title>
	<line x1="1219.6" y1="1195.8" x2="1227.3" y2="1194.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-18 New Zealand: 6 samples</title>
	<line x1="1227.3" y1="1194.2" x2="1231.0" y2="1193.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-18  G21624T  Australia=2 [3.6%]  surface glycoprotein, R21I</title>
	<circle cx="1385.0" cy="1160.7" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  G21795A  New Zealand=2 [33.3%]  surface glycoprotein, R78K</title>
	<circle cx="1422.2" cy="1152.8" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  A23403G  Australia=29 [52.7%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1078.3" r="6.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  A23403G  New Zealand=2 [33.3%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1078.3" r="6.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19 Australia: 91 samples</title>
	<line x1="1219.6" y1="1196.2" x2="1228.3" y2="1194.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-19 New Zealand: 5 samples</title>
	<line x1="1228.3" y1="1194.5" x2="1231.7" y2="1193.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-19  A23403G  New Zealand=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1088.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19  A23403G  Australia=50 [54.9%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1088.3" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20 Australia: 136 samples</title>
	<line x1="1219.7" y1="1196.5" x2="1229.2" y2="1194.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20 New Zealand: 24 samples</title>
	<line x1="1229.2" y1="1194.9" x2="1235.4" y2="1193.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20  A23403G  New Zealand=11 [45.8%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="6.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  A23403G  Australia=50 [36.8%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  C25350T  Australia=2 [1.5%]  surface glycoprotein, P1263L</title>
	<circle cx="2203.5" cy="1023.1" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21 Australia: 135 samples</title>
	<line x1="1219.8" y1="1196.9" x2="1229.2" y2="1195.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-21 New Zealand: 18 samples</title>
	<line x1="1229.2" y1="1195.4" x2="1234.9" y2="1194.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-21  C21614T  Australia=2 [1.5%]  surface glycoprotein, L18F</title>
	<circle cx="1384.6" cy="1170.8" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  C21711T  Australia=3 [2.2%]  surface glycoprotein, S50L</title>
	<circle cx="1405.9" cy="1167.4" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  C22227T  Australia=2 [1.5%]  surface glycoprotein, A222V</title>
	<circle cx="1519.4" cy="1149.4" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  A23403G  New Zealand=13 [72.2%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1108.4" r="7.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  A23403G  Australia=64 [47.4%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1108.4" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  C23439T  Australia=6 [4.4%]  surface glycoprotein, A626V</title>
	<circle cx="1786.0" cy="1107.2" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21  G24053T  Australia=2 [1.5%]  surface glycoprotein, A831S</title>
	<circle cx="1921.1" cy="1085.8" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22 Australia: 178 samples</title>
	<line x1="1219.8" y1="1197.2" x2="1229.8" y2="1195.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-22 New Zealand: 15 samples</title>
	<line x1="1229.8" y1="1195.8" x2="1235.2" y2="1195.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-22  A23403G  Australia=98 [55.1%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1118.5" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  A23403G  New Zealand=6 [40.0%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1118.5" r="6.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  C23439T  Australia=3 [1.7%]  surface glycoprotein, A626V</title>
	<circle cx="1787.5" cy="1117.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  G24053T  Australia=2 [1.1%]  surface glycoprotein, A831S</title>
	<circle cx="1923.0" cy="1098.4" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  G24933T  Australia=8 [4.5%]  surface glycoprotein, G1124V</title>
	<circle cx="2117.0" cy="1071.1" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22  G25429T  Australia=2 [1.1%]  ORF3a protein, V13L</title>
	<circle cx="2226.4" cy="1055.7" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23 Australia: 141 samples</title>
	<line x1="1219.9" y1="1197.6" x2="1229.5" y2="1196.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-23 New Zealand: 24 samples</title>
	<line x1="1229.5" y1="1196.4" x2="1235.7" y2="1195.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-23  C22326T  Australia=2 [1.4%]  surface glycoprotein, S255F</title>
	<circle cx="1542.9" cy="1157.9" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  A23403G  Australia=83 [58.9%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1128.7" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  A23403G  New Zealand=11 [45.8%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1128.7" r="6.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  C23439T  Australia=6 [4.3%]  surface glycoprotein, A626V</title>
	<circle cx="1788.9" cy="1127.7" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-23  G24933T  Australia=11 [7.8%]  surface glycoprotein, G1124V</title>
	<circle cx="2119.2" cy="1087.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24 Australia: 99 samples</title>
	<line x1="1219.9" y1="1197.9" x2="1228.8" y2="1197.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24 New Zealand: 19 samples</title>
	<line x1="1228.8" y1="1197.0" x2="1234.7" y2="1196.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24 Guam: 2 samples</title>
	<line x1="1234.7" y1="1196.4" x2="1236.8" y2="1196.1" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24  A23403G  Australia=56 [56.6%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1138.8" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  A23403G  Australia=56 [56.6%] New Zealand=10 [52.6%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1138.8" r="6.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  G24933T  Australia=9 [9.1%]  surface glycoprotein, G1124V</title>
	<circle cx="2121.0" cy="1103.2" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  G25429T  Australia=2 [2.0%]  ORF3a protein, V13L</title>
	<circle cx="2230.8" cy="1091.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25 Australia: 121 samples</title>
	<line x1="1219.9" y1="1198.3" x2="1229.3" y2="1197.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-25 New Zealand: 22 samples</title>
	<line x1="1229.3" y1="1197.4" x2="1235.4" y2="1196.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-25  C21575T  Australia=2 [1.7%]  surface glycoprotein, L5F</title>
	<circle cx="1377.5" cy="1184.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  A23403G  New Zealand=18 [81.8%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1149.0" r="7.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  A23403G  Australia=61 [50.4%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1149.0" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  C23430T  Australia=3 [2.5%]  surface glycoprotein, A623V</title>
	<circle cx="1789.1" cy="1148.5" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  C23439T  Australia=4 [3.3%]  surface glycoprotein, A626V</title>
	<circle cx="1791.1" cy="1148.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25  G24933T  Australia=5 [4.1%]  surface glycoprotein, G1124V</title>
	<circle cx="2122.5" cy="1119.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26 Australia: 106 samples</title>
	<line x1="1220.0" y1="1198.6" x2="1229.1" y2="1198.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-26 New Zealand: 35 samples</title>
	<line x1="1229.1" y1="1198.0" x2="1236.0" y2="1197.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-26  A23403G  New Zealand=30 [85.7%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1159.2" r="7.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  A23403G  Australia=68 [64.2%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1159.2" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C23430T  Australia=2 [1.9%]  surface glycoprotein, A623V</title>
	<circle cx="1789.9" cy="1158.8" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C23439T  Australia=2 [1.9%]  surface glycoprotein, A626V</title>
	<circle cx="1791.9" cy="1158.6" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  G24933T  Australia=2 [1.9%]  surface glycoprotein, G1124V</title>
	<circle cx="2123.8" cy="1135.4" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26  C25350T  Australia=2 [1.9%]  surface glycoprotein, P1263L</title>
	<circle cx="2216.4" cy="1128.9" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27 Australia: 99 samples</title>
	<line x1="1220.0" y1="1199.0" x2="1229.0" y2="1198.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27 New Zealand: 27 samples</title>
	<line x1="1229.0" y1="1198.5" x2="1235.5" y2="1198.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27  A23403G  New Zealand=23 [85.2%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1169.4" r="7.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  A23403G  Australia=57 [57.6%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1169.4" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  C23430T  Australia=4 [4.0%]  surface glycoprotein, A623V</title>
	<circle cx="1790.5" cy="1169.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  C23439T  Australia=5 [5.1%]  surface glycoprotein, A626V</title>
	<circle cx="1792.5" cy="1168.9" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28 Australia: 72 samples</title>
	<line x1="1220.0" y1="1199.3" x2="1228.4" y2="1199.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-28 New Zealand: 12 samples</title>
	<line x1="1228.4" y1="1199.0" x2="1233.4" y2="1198.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-28  A23403G  New Zealand=11 [91.7%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1179.6" r="7.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28  A23403G  Australia=49 [68.1%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1179.6" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28  C23430T  Australia=2 [2.8%]  surface glycoprotein, A623V</title>
	<circle cx="1791.0" cy="1179.4" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-28  C23439T  Australia=2 [2.8%]  surface glycoprotein, A626V</title>
	<circle cx="1793.0" cy="1179.3" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29 Australia: 53 samples</title>
	<line x1="1220.0" y1="1199.7" x2="1227.8" y2="1199.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-29 New Zealand: 6 samples</title>
	<line x1="1227.8" y1="1199.5" x2="1231.6" y2="1199.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-29  A23403G  New Zealand=5 [83.3%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1189.8" r="7.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29  A23403G  Australia=40 [75.5%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1189.8" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30 Australia: 69 samples</title>
	<line x1="1220.0" y1="1200.0" x2="1228.3" y2="1200.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-30 New Zealand: 12 samples</title>
	<line x1="1228.3" y1="1200.0" x2="1233.3" y2="1200.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-30  C21707T  Australia=2 [2.9%]  surface glycoprotein, H49Y</title>
	<circle cx="1407.6" cy="1200.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  A23403G  Australia=48 [69.6%]  surface glycoprotein, D614G</title>
	<circle cx="1785.3" cy="1200.0" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  A23403G  New Zealand=7 [58.3%]  surface glycoprotein, D614G</title>
	<circle cx="1785.3" cy="1200.0" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  C23439T  Australia=2 [2.9%]  surface glycoprotein, A626V</title>
	<circle cx="1793.3" cy="1200.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31 Australia: 69 samples</title>
	<line x1="1220.0" y1="1200.3" x2="1228.3" y2="1200.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-31 New Zealand: 12 samples</title>
	<line x1="1228.3" y1="1200.5" x2="1233.3" y2="1200.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-31  C21597T  Australia=2 [2.9%]  surface glycoprotein, S12F</title>
	<circle cx="1383.0" cy="1203.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  G23282T  Australia=2 [2.9%]  surface glycoprotein, D574Y</title>
	<circle cx="1758.3" cy="1209.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  A23403G  Australia=52 [75.4%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1210.2" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  A23403G  New Zealand=8 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1210.2" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01 Australia: 55 samples</title>
	<line x1="1220.0" y1="1200.7" x2="1227.8" y2="1201.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01 New Zealand: 31 samples</title>
	<line x1="1227.8" y1="1201.0" x2="1234.6" y2="1201.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01  A23403G  New Zealand=25 [80.6%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  A23403G  Australia=41 [74.5%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02 Australia: 37 samples</title>
	<line x1="1220.0" y1="1201.0" x2="1227.1" y2="1201.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-02 New Zealand: 11 samples</title>
	<line x1="1227.1" y1="1201.4" x2="1231.9" y2="1201.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-02  A23403G  New Zealand=9 [81.8%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1230.6" r="7.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  A23403G  Australia=26 [70.3%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1230.6" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03 Australia: 34 samples</title>
	<line x1="1220.0" y1="1201.4" x2="1226.9" y2="1201.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-03 New Zealand: 9 samples</title>
	<line x1="1226.9" y1="1201.9" x2="1231.4" y2="1202.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-03  A23403G  New Zealand=8 [88.9%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1240.8" r="7.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03  A23403G  Australia=23 [67.6%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1240.8" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04 Australia: 40 samples</title>
	<line x1="1219.9" y1="1201.7" x2="1227.2" y2="1202.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-04 New Zealand: 8 samples</title>
	<line x1="1227.2" y1="1202.4" x2="1231.4" y2="1202.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-04  A23403G  New Zealand=7 [87.5%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1251.0" r="7.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  A23403G  Australia=29 [72.5%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1251.0" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  G24077T  New Zealand=2 [25.0%]  surface glycoprotein, D839Y</title>
	<circle cx="1932.6" cy="1264.1" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  C24138T  Australia=5 [12.5%]  surface glycoprotein, T859I</title>
	<circle cx="1946.1" cy="1265.3" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  G24368T  Australia=2 [5.0%]  surface glycoprotein, D936Y</title>
	<circle cx="1997.2" cy="1269.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04  C25350T  Australia=6 [15.0%]  surface glycoprotein, P1263L</title>
	<circle cx="2215.1" cy="1288.8" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05 Australia: 34 samples</title>
	<line x1="1219.9" y1="1202.1" x2="1226.8" y2="1202.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-05 New Zealand: 11 samples</title>
	<line x1="1226.8" y1="1202.8" x2="1231.6" y2="1203.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-05  G21974C  Australia=3 [8.8%]  surface glycoprotein, D138H</title>
	<circle cx="1465.6" cy="1227.9" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  A23403G  New Zealand=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1261.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  A23403G  Australia=23 [67.6%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1261.2" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05  C23453T  New Zealand=2 [18.2%]  surface glycoprotein, P631S</title>
	<circle cx="1793.2" cy="1262.3" r="5.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06 Australia: 32 samples</title>
	<line x1="1219.9" y1="1202.4" x2="1226.6" y2="1203.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-06 New Zealand: 8 samples</title>
	<line x1="1226.6" y1="1203.3" x2="1230.9" y2="1203.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-06  A23403G  New Zealand=7 [87.5%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1271.3" r="7.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  A23403G  Australia=18 [56.2%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1271.3" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  G24077T  New Zealand=2 [25.0%]  surface glycoprotein, D839Y</title>
	<circle cx="1929.9" cy="1289.6" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07 Australia: 24 samples</title>
	<line x1="1219.8" y1="1202.8" x2="1226.0" y2="1203.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-07 New Zealand: 5 samples</title>
	<line x1="1226.0" y1="1203.7" x2="1229.5" y2="1204.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-07  A23403G  Australia=16 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1281.5" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07  A23403G  New Zealand=3 [60.0%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1281.5" r="7.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08 Australia: 30 samples</title>
	<line x1="1219.8" y1="1203.1" x2="1226.4" y2="1204.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-08 New Zealand: 4 samples</title>
	<line x1="1226.4" y1="1204.2" x2="1229.5" y2="1204.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-08  A23403G  New Zealand=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1291.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  A23403G  Australia=23 [76.7%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1291.6" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09 Australia: 33 samples</title>
	<line x1="1219.7" y1="1203.5" x2="1226.5" y2="1204.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-09 New Zealand: 5 samples</title>
	<line x1="1226.5" y1="1204.7" x2="1229.9" y2="1205.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-09  A23403G  New Zealand=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1301.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  A23403G  Australia=24 [72.7%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1301.6" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  G24077T  New Zealand=4 [80.0%]  surface glycoprotein, D839Y</title>
	<circle cx="1924.2" cy="1327.7" r="7.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  C25350T  Australia=3 [9.1%]  surface glycoprotein, P1263L</title>
	<circle cx="2203.5" cy="1376.9" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10 Australia: 19 samples</title>
	<line x1="1219.6" y1="1203.8" x2="1225.4" y2="1204.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-10 New Zealand: 4 samples</title>
	<line x1="1225.4" y1="1204.9" x2="1228.5" y2="1205.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-10  A23403G  New Zealand=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1311.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  A23403G  Australia=9 [47.4%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1311.7" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10  G24077T  New Zealand=2 [50.0%]  surface glycoprotein, D839Y</title>
	<circle cx="1921.9" cy="1340.3" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11 Australia: 18 samples</title>
	<line x1="1219.6" y1="1204.2" x2="1225.2" y2="1205.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-11 New Zealand: 3 samples</title>
	<line x1="1225.2" y1="1205.4" x2="1227.8" y2="1205.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-11  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1321.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11  A23403G  Australia=10 [55.6%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1321.7" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11  G24933T  Australia=2 [11.1%]  surface glycoprotein, G1124V</title>
	<circle cx="2105.8" cy="1392.5" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-11  C25469T  Australia=2 [11.1%]  ORF3a protein, S26L</title>
	<circle cx="2222.6" cy="1417.4" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12 Australia: 8 samples</title>
	<line x1="1219.5" y1="1204.5" x2="1223.7" y2="1205.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-12 New Zealand: 2 samples</title>
	<line x1="1223.7" y1="1205.5" x2="1225.8" y2="1205.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-12  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1331.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12  A23403G  Australia=6 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1331.7" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12  G24077T  New Zealand=2 [100.0%]  surface glycoprotein, D839Y</title>
	<circle cx="1916.6" cy="1365.4" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13 Australia: 24 samples</title>
	<line x1="1219.4" y1="1204.8" x2="1225.5" y2="1206.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-13  A23403G  Australia=10 [41.7%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1341.6" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14 Australia: 29 samples</title>
	<line x1="1219.3" y1="1205.2" x2="1225.7" y2="1206.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-14  A23403G  Australia=24 [82.8%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1351.5" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15 Australia: 12 samples</title>
	<line x1="1219.2" y1="1205.5" x2="1224.0" y2="1206.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15 New Zealand: 11 samples</title>
	<line x1="1224.0" y1="1206.9" x2="1228.7" y2="1208.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15  A23403G  New Zealand=9 [81.8%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1361.3" r="7.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  A23403G  Australia=6 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1361.3" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16 Australia: 6 samples</title>
	<line x1="1219.1" y1="1205.8" x2="1222.8" y2="1207.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-16  A23403G  Australia=4 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1371.1" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17 Australia: 14 samples</title>
	<line x1="1219.0" y1="1206.2" x2="1224.1" y2="1207.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-17 New Zealand: 2 samples</title>
	<line x1="1224.1" y1="1207.8" x2="1226.1" y2="1208.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-17  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1380.9" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  A23403G  Australia=13 [92.9%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1380.9" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  G24077T  New Zealand=2 [100.0%]  surface glycoprotein, D839Y</title>
	<circle cx="1899.4" cy="1427.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18 Australia: 4 samples</title>
	<line x1="1218.9" y1="1206.5" x2="1221.9" y2="1207.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-19 Australia: 4 samples</title>
	<line x1="1218.8" y1="1206.8" x2="1221.7" y2="1207.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-19  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1750.0" cy="1400.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20 Australia: 4 samples</title>
	<line x1="1218.7" y1="1207.2" x2="1221.6" y2="1208.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-20 New Zealand: 2 samples</title>
	<line x1="1221.6" y1="1208.3" x2="1223.6" y2="1209.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-20  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="1409.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  A23403G  Australia=4 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="1409.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21 Australia: 7 samples</title>
	<line x1="1218.5" y1="1207.5" x2="1222.3" y2="1209.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-21  A23403G  Australia=3 [42.9%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="1419.3" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22 Australia: 3 samples</title>
	<line x1="1218.4" y1="1207.8" x2="1220.9" y2="1208.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23 Australia: 7 samples</title>
	<line x1="1218.3" y1="1208.1" x2="1222.0" y2="1209.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23  A23403G  Australia=5 [71.4%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="1438.1" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25 New Zealand: 8 samples</title>
	<line x1="1218.0" y1="1208.8" x2="1221.8" y2="1210.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-25  A23403G  New Zealand=6 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1726.1" cy="1456.6" r="7.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26 Australia: 2 samples</title>
	<line x1="1217.8" y1="1209.1" x2="1219.7" y2="1210.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-26  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1721.5" cy="1465.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27 Australia: 7 samples</title>
	<line x1="1217.7" y1="1209.4" x2="1221.2" y2="1211.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-27  A23403G  Australia=2 [28.6%]  surface glycoprotein, D614G</title>
	<circle cx="1716.8" cy="1474.8" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28 Australia: 4 samples</title>
	<line x1="1217.5" y1="1209.7" x2="1220.2" y2="1211.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-28  A23403G  Australia=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1711.9" cy="1483.8" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29 Australia: 6 samples</title>
	<line x1="1217.3" y1="1210.0" x2="1220.6" y2="1211.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-29 New Zealand: 2 samples</title>
	<line x1="1220.6" y1="1211.9" x2="1222.5" y2="1213.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-29  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="1492.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  A23403G  Australia=3 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="1492.7" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30 Australia: 4 samples</title>
	<line x1="1217.1" y1="1210.3" x2="1219.8" y2="1211.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30  A23403G  Australia=2 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01 Australia: 3 samples</title>
	<line x1="1217.0" y1="1210.6" x2="1219.3" y2="1212.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-01  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1696.4" cy="1510.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02 Australia: 9 samples</title>
	<line x1="1216.8" y1="1210.9" x2="1220.5" y2="1213.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-02  G23224T  Australia=2 [22.2%]  surface glycoprotein, E554D</title>
	<circle cx="1657.4" cy="1497.1" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02  A23403G  Australia=7 [77.8%]  surface glycoprotein, D614G</title>
	<circle cx="1690.9" cy="1518.8" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03 Australia: 4 samples</title>
	<line x1="1216.6" y1="1211.2" x2="1219.2" y2="1212.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-03  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1685.2" cy="1527.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04 Australia: 4 samples</title>
	<line x1="1216.4" y1="1211.5" x2="1219.0" y2="1213.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-04  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1679.5" cy="1535.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05 Australia: 6 samples</title>
	<line x1="1216.2" y1="1211.8" x2="1219.3" y2="1214.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-05  G23015C  Australia=3 [50.0%]  surface glycoprotein, G485R</title>
	<circle cx="1603.6" cy="1493.2" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  A23403G  Australia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1673.5" cy="1544.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06 Australia: 7 samples</title>
	<line x1="1216.0" y1="1212.0" x2="1219.2" y2="1214.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-06  A23403G  Australia=6 [85.7%]  surface glycoprotein, D614G</title>
	<circle cx="1667.4" cy="1552.2" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07 Australia: 6 samples</title>
	<line x1="1215.8" y1="1212.3" x2="1218.8" y2="1214.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-07  A23403G  Australia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1661.2" cy="1560.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08 Australia: 2 samples</title>
	<line x1="1215.5" y1="1212.6" x2="1217.2" y2="1213.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-08  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1654.9" cy="1568.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09 Australia: 6 samples</title>
	<line x1="1215.3" y1="1212.9" x2="1218.2" y2="1215.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-09 New Zealand: 2 samples</title>
	<line x1="1218.2" y1="1215.3" x2="1219.9" y2="1216.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-09  G23015C  Australia=3 [50.0%]  surface glycoprotein, G485R</title>
	<circle cx="1582.2" cy="1520.7" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09  A23403G  Australia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1648.4" cy="1576.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09  A23403G  Australia=6 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1648.4" cy="1576.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-10 Australia: 6 samples</title>
	<line x1="1215.1" y1="1213.1" x2="1218.0" y2="1215.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-10  A23403G  Australia=5 [83.3%]  surface glycoprotein, D614G</title>
	<circle cx="1641.7" cy="1584.0" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11 Australia: 4 samples</title>
	<line x1="1214.9" y1="1213.4" x2="1217.2" y2="1215.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-11  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1635.0" cy="1591.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12 Australia: 12 samples</title>
	<line x1="1214.6" y1="1213.6" x2="1218.3" y2="1217.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-12  G23015C  Australia=7 [58.3%]  surface glycoprotein, G485R</title>
	<circle cx="1564.9" cy="1540.2" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  A23403G  Australia=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1628.1" cy="1599.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13 Australia: 3 samples</title>
	<line x1="1214.4" y1="1213.9" x2="1216.3" y2="1215.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-13  A23403G  Australia=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1621.0" cy="1606.6" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14 Australia: 3 samples</title>
	<line x1="1214.1" y1="1214.1" x2="1216.1" y2="1216.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-15 Australia: 2 samples</title>
	<line x1="1213.9" y1="1214.4" x2="1215.4" y2="1215.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-15  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1606.6" cy="1621.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16 Australia: 3 samples</title>
	<line x1="1213.6" y1="1214.6" x2="1215.5" y2="1216.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-16  A23403G  Australia=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1599.2" cy="1628.1" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19 Australia: 4 samples</title>
	<line x1="1212.9" y1="1215.3" x2="1214.9" y2="1217.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-19  G22992A  Australia=4 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="1517.4" cy="1578.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20 Australia: 3 samples</title>
	<line x1="1212.6" y1="1215.5" x2="1214.3" y2="1217.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-20  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1568.3" cy="1654.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23 Australia: 2 samples</title>
	<line x1="1211.8" y1="1216.2" x2="1213.0" y2="1217.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-24 Australia: 2 samples</title>
	<line x1="1211.5" y1="1216.4" x2="1212.7" y2="1218.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-25 Australia: 3 samples</title>
	<line x1="1211.2" y1="1216.6" x2="1212.7" y2="1218.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-25  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1527.3" cy="1685.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27 Australia: 10 samples</title>
	<line x1="1210.6" y1="1217.0" x2="1213.1" y2="1220.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-27  G22992A  Australia=2 [20.0%]  surface glycoprotein, S477N</title>
	<circle cx="1461.7" cy="1618.7" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  G23015C  Australia=3 [30.0%]  surface glycoprotein, G485R</title>
	<circle cx="1464.4" cy="1623.1" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27  A23403G  Australia=7 [70.0%]  surface glycoprotein, D614G</title>
	<circle cx="1510.2" cy="1696.4" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28 Australia: 12 samples</title>
	<line x1="1210.3" y1="1217.1" x2="1212.9" y2="1221.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-28  G22992A  Australia=4 [33.3%]  surface glycoprotein, S477N</title>
	<circle cx="1454.3" cy="1623.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  G23015C  Australia=3 [25.0%]  surface glycoprotein, G485R</title>
	<circle cx="1456.9" cy="1627.6" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28  A23403G  Australia=8 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1501.5" cy="1701.7" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-29 Australia: 3 samples</title>
	<line x1="1210.0" y1="1217.3" x2="1211.4" y2="1219.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-30 Australia: 6 samples</title>
	<line x1="1209.7" y1="1217.5" x2="1211.5" y2="1220.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-30  G22992A  Australia=3 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="1439.4" cy="1631.9" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  A23403G  Australia=3 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1483.8" cy="1711.9" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31 Australia: 4 samples</title>
	<line x1="1209.4" y1="1217.7" x2="1210.9" y2="1220.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-31  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1474.8" cy="1716.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01 Australia: 4 samples</title>
	<line x1="1209.1" y1="1217.8" x2="1210.5" y2="1220.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-01  A23403G  Australia=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1465.7" cy="1721.5" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-03 Australia: 2 samples</title>
	<line x1="1208.5" y1="1218.1" x2="1209.4" y2="1220.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-03  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1447.4" cy="1730.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05 Australia: 4 samples</title>
	<line x1="1207.8" y1="1218.4" x2="1209.0" y2="1221.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-05  G22992A  Australia=3 [75.0%]  surface glycoprotein, S477N</title>
	<circle cx="1392.9" cy="1654.5" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-06 Australia: 3 samples</title>
	<line x1="1207.5" y1="1218.5" x2="1208.5" y2="1221.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-06  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1419.3" cy="1742.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-07 Australia: 2 samples</title>
	<line x1="1207.2" y1="1218.7" x2="1207.9" y2="1220.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-07  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1409.8" cy="1746.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-08 Australia: 2 samples</title>
	<line x1="1206.8" y1="1218.8" x2="1207.6" y2="1220.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-09 Australia: 9 samples</title>
	<line x1="1206.5" y1="1218.9" x2="1208.0" y2="1223.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-09  G22992A  Australia=4 [44.4%]  surface glycoprotein, S477N</title>
	<circle cx="1360.8" cy="1666.9" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09  A23403G  Australia=5 [55.6%]  surface glycoprotein, D614G</title>
	<circle cx="1390.6" cy="1753.4" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10 Australia: 6 samples</title>
	<line x1="1206.2" y1="1219.0" x2="1207.4" y2="1222.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-10  G22992A  Australia=2 [33.3%]  surface glycoprotein, S477N</title>
	<circle cx="1352.6" cy="1669.6" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  A23403G  Australia=4 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1380.9" cy="1756.7" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11 Australia: 8 samples</title>
	<line x1="1205.8" y1="1219.1" x2="1207.1" y2="1223.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-11  G22992A  Australia=4 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="1344.4" cy="1672.2" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  A23403G  Australia=4 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1371.1" cy="1759.7" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12 Australia: 11 samples</title>
	<line x1="1205.5" y1="1219.2" x2="1206.9" y2="1223.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-12  G22992A  Australia=4 [36.4%]  surface glycoprotein, S477N</title>
	<circle cx="1336.1" cy="1674.6" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  A23063T  Australia=3 [27.3%]  surface glycoprotein, N501Y</title>
	<circle cx="1340.5" cy="1689.8" r="5.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  A23403G  Australia=7 [63.6%]  surface glycoprotein, D614G</title>
	<circle cx="1361.3" cy="1762.6" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  G25088T  Australia=2 [18.2%]  surface glycoprotein, V1176F</title>
	<circle cx="1464.8" cy="2123.4" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13 Australia: 8 samples</title>
	<line x1="1205.2" y1="1219.3" x2="1206.3" y2="1223.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-13  G22992A  Australia=6 [75.0%]  surface glycoprotein, S477N</title>
	<circle cx="1327.8" cy="1676.9" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  A23403G  Australia=2 [25.0%]  surface glycoprotein, D614G</title>
	<circle cx="1351.5" cy="1765.4" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14 Australia: 10 samples</title>
	<line x1="1204.8" y1="1219.4" x2="1206.0" y2="1224.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-14  G22992A  Australia=3 [30.0%]  surface glycoprotein, S477N</title>
	<circle cx="1319.5" cy="1679.1" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14  A23403G  Australia=7 [70.0%]  surface glycoprotein, D614G</title>
	<circle cx="1341.6" cy="1767.9" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15 Australia: 15 samples</title>
	<line x1="1204.5" y1="1219.5" x2="1205.7" y2="1224.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-15  G22992A  Australia=9 [60.0%]  surface glycoprotein, S477N</title>
	<circle cx="1311.1" cy="1681.1" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A23063T  Australia=2 [13.3%]  surface glycoprotein, N501Y</title>
	<circle cx="1314.6" cy="1696.5" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15  A23403G  Australia=5 [33.3%]  surface glycoprotein, D614G</title>
	<circle cx="1331.7" cy="1770.3" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16 Australia: 16 samples</title>
	<line x1="1204.2" y1="1219.6" x2="1205.3" y2="1225.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-16  G22992A  Australia=8 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="1302.7" cy="1683.0" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  A23403G  Australia=8 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1321.7" cy="1772.5" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17 Australia: 13 samples</title>
	<line x1="1203.8" y1="1219.6" x2="1204.8" y2="1224.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-17  G22992A  Australia=6 [46.2%]  surface glycoprotein, S477N</title>
	<circle cx="1294.2" cy="1684.7" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23063T  Australia=3 [23.1%]  surface glycoprotein, N501Y</title>
	<circle cx="1297.2" cy="1700.2" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23403G  Australia=7 [53.8%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="1774.5" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18 Australia: 6 samples</title>
	<line x1="1203.5" y1="1219.7" x2="1204.1" y2="1223.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-18  G22992A  Australia=2 [33.3%]  surface glycoprotein, S477N</title>
	<circle cx="1285.7" cy="1686.3" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A23063T  Australia=2 [33.3%]  surface glycoprotein, N501Y</title>
	<circle cx="1288.5" cy="1701.8" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A23403G  Australia=4 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="1776.4" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19 Australia: 20 samples</title>
	<line x1="1203.1" y1="1219.8" x2="1204.1" y2="1225.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-19  C21627T  Australia=2 [10.0%]  surface glycoprotein, T22I</title>
	<circle cx="1229.7" cy="1387.4" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  G22992A  Australia=7 [35.0%]  surface glycoprotein, S477N</title>
	<circle cx="1277.2" cy="1687.7" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23063T  Australia=2 [10.0%]  surface glycoprotein, N501Y</title>
	<circle cx="1279.7" cy="1703.3" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23403G  Australia=11 [55.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="1778.1" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20 Australia: 11 samples</title>
	<line x1="1202.8" y1="1219.8" x2="1203.5" y2="1224.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-20  G22992A  Australia=4 [36.4%]  surface glycoprotein, S477N</title>
	<circle cx="1268.7" cy="1689.0" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  A23403G  Australia=7 [63.6%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="1779.6" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21 Australia: 9 samples</title>
	<line x1="1202.4" y1="1219.9" x2="1203.0" y2="1224.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-21  G22992A  Australia=5 [55.6%]  surface glycoprotein, S477N</title>
	<circle cx="1260.2" cy="1690.1" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21  A23403G  Australia=4 [44.4%]  surface glycoprotein, D614G</title>
	<circle cx="1271.3" cy="1780.9" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22 Australia: 12 samples</title>
	<line x1="1202.1" y1="1219.9" x2="1202.6" y2="1224.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-22  G22992A  Australia=7 [58.3%]  surface glycoprotein, S477N</title>
	<circle cx="1251.6" cy="1691.1" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-22  A23403G  Australia=4 [33.3%]  surface glycoprotein, D614G</title>
	<circle cx="1261.2" cy="1782.1" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23 Australia: 24 samples</title>
	<line x1="1201.7" y1="1219.9" x2="1202.3" y2="1226.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-23  G22992A  Australia=18 [75.0%]  surface glycoprotein, S477N</title>
	<circle cx="1243.0" cy="1691.9" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  A23063T  Australia=4 [16.7%]  surface glycoprotein, N501Y</title>
	<circle cx="1244.4" cy="1707.6" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  A23403G  Australia=6 [25.0%]  surface glycoprotein, D614G</title>
	<circle cx="1251.0" cy="1783.1" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24 Australia: 38 samples</title>
	<line x1="1201.4" y1="1220.0" x2="1201.9" y2="1227.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-24  G22992A  Australia=31 [81.6%]  surface glycoprotein, S477N</title>
	<circle cx="1234.4" cy="1692.6" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  A23063T  Australia=4 [10.5%]  surface glycoprotein, N501Y</title>
	<circle cx="1235.5" cy="1708.3" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  A23403G  Australia=7 [18.4%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="1783.9" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25 Australia: 40 samples</title>
	<line x1="1201.0" y1="1220.0" x2="1201.4" y2="1227.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-25  G22992A  Australia=35 [87.5%]  surface glycoprotein, S477N</title>
	<circle cx="1225.8" cy="1693.1" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  GGA23401AGG  Australia=3 [7.5%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="1784.1" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  A23403G  Australia=5 [12.5%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="1784.5" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26 Australia: 52 samples</title>
	<line x1="1200.7" y1="1220.0" x2="1201.0" y2="1227.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-26  G22992A  Australia=44 [84.6%]  surface glycoprotein, S477N</title>
	<circle cx="1217.2" cy="1693.5" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  A23403G  Australia=7 [13.5%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="1784.9" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27 Australia: 40 samples</title>
	<line x1="1200.3" y1="1220.0" x2="1200.5" y2="1227.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-27  G22992A  Australia=30 [75.0%]  surface glycoprotein, S477N</title>
	<circle cx="1208.6" cy="1693.7" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  A23063T  Australia=2 [5.0%]  surface glycoprotein, N501Y</title>
	<circle cx="1208.9" cy="1709.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27  A23403G  Australia=10 [25.0%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="1785.2" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28 Australia: 46 samples</title>
	<line x1="1200.0" y1="1220.0" x2="1200.0" y2="1227.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-28  G22992A  Australia=41 [89.1%]  surface glycoprotein, S477N</title>
	<circle cx="1200.0" cy="1693.8" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-28  A23403G  Australia=5 [10.9%]  surface glycoprotein, D614G</title>
	<circle cx="1200.0" cy="1785.3" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29 Australia: 58 samples</title>
	<line x1="1199.7" y1="1220.0" x2="1199.5" y2="1228.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-29  G22992A  Australia=49 [84.5%]  surface glycoprotein, S477N</title>
	<circle cx="1191.4" cy="1693.7" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  GGA23401AGG  Australia=2 [3.4%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="1784.8" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A23403G  Australia=9 [15.5%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="1785.2" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G24095T  Australia=2 [3.4%]  surface glycoprotein, A845S</title>
	<circle cx="1187.1" cy="1939.3" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30 Australia: 54 samples</title>
	<line x1="1199.3" y1="1220.0" x2="1199.0" y2="1227.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-30  G22992A  Australia=45 [83.3%]  surface glycoprotein, S477N</title>
	<circle cx="1182.8" cy="1693.5" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A23403G  Australia=9 [16.7%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="1784.9" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01 Australia: 51 samples</title>
	<line x1="1199.0" y1="1220.0" x2="1198.5" y2="1227.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-01  G22992A  Australia=46 [90.2%]  surface glycoprotein, S477N</title>
	<circle cx="1174.2" cy="1693.1" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  A23063T  Australia=2 [3.9%]  surface glycoprotein, N501Y</title>
	<circle cx="1173.3" cy="1708.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  A23403G  Australia=5 [9.8%]  surface glycoprotein, D614G</title>
	<circle cx="1169.4" cy="1784.5" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02 Australia: 70 samples</title>
	<line x1="1198.6" y1="1220.0" x2="1198.0" y2="1228.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02  G22992A  Australia=63 [90.0%]  surface glycoprotein, S477N</title>
	<circle cx="1165.6" cy="1692.6" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23403G  Australia=7 [10.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  C23895T  Australia=7 [10.0%]  surface glycoprotein, T778I</title>
	<circle cx="1151.5" cy="1893.2" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G25088T  Australia=2 [2.9%]  surface glycoprotein, V1176F</title>
	<circle cx="1133.0" cy="2158.2" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G25352T  Australia=2 [2.9%]  surface glycoprotein, V1264L</title>
	<circle cx="1128.9" cy="2216.9" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03 Australia: 59 samples</title>
	<line x1="1198.3" y1="1219.9" x2="1197.6" y2="1227.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-03  G22992A  Australia=51 [86.4%]  surface glycoprotein, S477N</title>
	<circle cx="1157.0" cy="1691.9" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  GGA23401AGG  Australia=3 [5.1%]  surface glycoprotein, D614G</title>
	<circle cx="1149.0" cy="1782.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  A23403G  Australia=8 [13.6%]  surface glycoprotein, D614G</title>
	<circle cx="1149.0" cy="1783.1" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  G25249T  Australia=2 [3.4%]  surface glycoprotein, M1229I</title>
	<circle cx="1113.2" cy="2192.6" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04 Australia: 93 samples</title>
	<line x1="1197.9" y1="1219.9" x2="1197.0" y2="1228.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-04  G22021T  Australia=2 [2.2%]  surface glycoprotein, M153I</title>
	<circle cx="1171.0" cy="1476.0" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  G22335T  Australia=3 [3.2%]  surface glycoprotein, W258L</title>
	<circle cx="1163.7" cy="1545.5" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  G22992A  Australia=76 [81.7%]  surface glycoprotein, S477N</title>
	<circle cx="1148.4" cy="1691.1" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  G23311T  Australia=2 [2.2%]  surface glycoprotein, E583D</title>
	<circle cx="1141.0" cy="1761.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  A23403G  Australia=17 [18.3%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="1782.1" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  C23895T  Australia=2 [2.2%]  surface glycoprotein, T778I</title>
	<circle cx="1127.4" cy="1891.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  G25088T  Australia=2 [2.2%]  surface glycoprotein, V1176F</title>
	<circle cx="1099.6" cy="2155.3" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05 Australia: 93 samples</title>
	<line x1="1197.6" y1="1219.9" x2="1196.5" y2="1228.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-05  ATTA22190A  Australia=2 [2.2%]  surface glycoprotein, I210N</title>
	<circle cx="1161.6" cy="1512.8" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  G22992A  Australia=85 [91.4%]  surface glycoprotein, S477N</title>
	<circle cx="1139.8" cy="1690.1" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  GGA23401AGG  Australia=2 [2.2%]  surface glycoprotein, D614G</title>
	<circle cx="1128.7" cy="1780.5" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  A23403G  Australia=6 [6.5%]  surface glycoprotein, D614G</title>
	<circle cx="1128.7" cy="1780.9" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05  C23457A  Australia=3 [3.2%]  surface glycoprotein, T632N</title>
	<circle cx="1127.2" cy="1792.9" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06 Australia: 116 samples</title>
	<line x1="1197.2" y1="1219.8" x2="1195.9" y2="1229.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-06  G22992A  Australia=109 [94.0%]  surface glycoprotein, S477N</title>
	<circle cx="1131.3" cy="1689.0" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  GGA23401AGG  Australia=3 [2.6%]  surface glycoprotein, D614G</title>
	<circle cx="1118.6" cy="1779.2" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  A23403G  Australia=7 [6.0%]  surface glycoprotein, D614G</title>
	<circle cx="1118.5" cy="1779.6" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  C23457A  Australia=2 [1.7%]  surface glycoprotein, T632N</title>
	<circle cx="1116.9" cy="1791.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  C23895T  Australia=2 [1.7%]  surface glycoprotein, T778I</title>
	<circle cx="1103.3" cy="1888.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06  C25433T  Australia=3 [2.6%]  ORF3a protein, T14I</title>
	<circle cx="1055.6" cy="2227.3" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07 Australia: 149 samples</title>
	<line x1="1196.9" y1="1219.8" x2="1195.3" y2="1229.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-07  G22992A  Australia=138 [92.6%]  surface glycoprotein, S477N</title>
	<circle cx="1122.8" cy="1687.7" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  GGA23401AGG  Australia=6 [4.0%]  surface glycoprotein, D614G</title>
	<circle cx="1108.5" cy="1777.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  A23403G  Australia=11 [7.4%]  surface glycoprotein, D614G</title>
	<circle cx="1108.4" cy="1778.1" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C23457A  Australia=2 [1.3%]  surface glycoprotein, T632N</title>
	<circle cx="1106.6" cy="1790.0" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  C23895T  Australia=3 [2.0%]  surface glycoprotein, T778I</title>
	<circle cx="1091.3" cy="1886.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G24933T  Australia=2 [1.3%]  surface glycoprotein, G1124V</title>
	<circle cx="1055.1" cy="2114.7" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08 Australia: 132 samples</title>
	<line x1="1196.5" y1="1219.7" x2="1194.9" y2="1229.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-08  G22992A  Australia=125 [94.7%]  surface glycoprotein, S477N</title>
	<circle cx="1114.3" cy="1686.3" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  G23311C  Australia=2 [1.5%]  surface glycoprotein, E583D</title>
	<circle cx="1101.9" cy="1756.2" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  GGA23401AGG  Australia=3 [2.3%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="1776.0" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  A23403G  Australia=6 [4.5%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="1776.4" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  C23895T  Australia=2 [1.5%]  surface glycoprotein, T778I</title>
	<circle cx="1079.3" cy="1884.3" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09 Australia: 94 samples</title>
	<line x1="1196.2" y1="1219.6" x2="1194.5" y2="1228.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-09  G22992A  Australia=90 [95.7%]  surface glycoprotein, S477N</title>
	<circle cx="1105.8" cy="1684.7" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  GGA23401AGG  Australia=5 [5.3%]  surface glycoprotein, D614G</title>
	<circle cx="1088.4" cy="1774.1" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  A23403G  Australia=4 [4.3%]  surface glycoprotein, D614G</title>
	<circle cx="1088.3" cy="1774.5" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  C25433T  Australia=2 [2.1%]  ORF3a protein, T14I</title>
	<circle cx="1002.1" cy="2218.4" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10 Australia: 104 samples</title>
	<line x1="1195.8" y1="1219.6" x2="1194.0" y2="1228.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-10  G22992A  Australia=102 [98.1%]  surface glycoprotein, S477N</title>
	<circle cx="1097.3" cy="1683.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  GGA23401AGG  Australia=3 [2.9%]  surface glycoprotein, D614G</title>
	<circle cx="1078.4" cy="1772.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  A23403G  Australia=2 [1.9%]  surface glycoprotein, D614G</title>
	<circle cx="1078.3" cy="1772.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  C23895T  Australia=5 [4.8%]  surface glycoprotein, T778I</title>
	<circle cx="1055.5" cy="1879.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11 Australia: 81 samples</title>
	<line x1="1195.5" y1="1219.5" x2="1193.6" y2="1227.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-11  G22992A  Australia=80 [98.8%]  surface glycoprotein, S477N</title>
	<circle cx="1088.9" cy="1681.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11  GGA23401AGG  Australia=2 [2.5%]  surface glycoprotein, D614G</title>
	<circle cx="1068.4" cy="1769.9" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11  G24933T  Australia=5 [6.2%]  surface glycoprotein, G1124V</title>
	<circle cx="991.7" cy="2102.3" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-12 Australia: 91 samples</title>
	<line x1="1195.2" y1="1219.4" x2="1193.0" y2="1228.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-12  G22992A  Australia=88 [96.7%]  surface glycoprotein, S477N</title>
	<circle cx="1080.5" cy="1679.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-12  A23403G  Australia=2 [2.2%]  surface glycoprotein, D614G</title>
	<circle cx="1058.4" cy="1767.9" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-12  C23895T  Australia=2 [2.2%]  surface glycoprotein, T778I</title>
	<circle cx="1031.9" cy="1874.2" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13 Australia: 231 samples</title>
	<line x1="1194.8" y1="1219.3" x2="1192.1" y2="1229.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-13  C22323T  Australia=4 [1.7%]  surface glycoprotein, S254F</title>
	<circle cx="1110.8" cy="1533.0" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  G22992A  Australia=225 [97.4%]  surface glycoprotein, S477N</title>
	<circle cx="1072.2" cy="1676.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  GGA23401AGG  Australia=4 [1.7%]  surface glycoprotein, D614G</title>
	<circle cx="1048.6" cy="1764.9" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  A23403G  Australia=4 [1.7%]  surface glycoprotein, D614G</title>
	<circle cx="1048.5" cy="1765.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  C23457A  Australia=2 [0.9%]  surface glycoprotein, T632N</title>
	<circle cx="1045.4" cy="1777.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  C23655T  Australia=4 [1.7%]  surface glycoprotein, S698L</title>
	<circle cx="1034.0" cy="1819.6" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  G25249T  Australia=3 [1.3%]  surface glycoprotein, M1229I</title>
	<circle cx="942.1" cy="2162.5" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14 Australia: 183 samples</title>
	<line x1="1194.5" y1="1219.2" x2="1191.7" y2="1229.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-14  G22992A  Australia=181 [98.9%]  surface glycoprotein, S477N</title>
	<circle cx="1063.9" cy="1674.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  GGA23401AGG  Australia=6 [3.3%]  surface glycoprotein, D614G</title>
	<circle cx="1038.8" cy="1762.2" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A23403G  Australia=2 [1.1%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="1762.6" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  C23457A  Australia=4 [2.2%]  surface glycoprotein, T632N</title>
	<circle cx="1035.4" cy="1774.2" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  C23709T  Australia=2 [1.1%]  surface glycoprotein, T716I</title>
	<circle cx="1019.9" cy="1828.1" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15 Australia: 166 samples</title>
	<line x1="1194.2" y1="1219.1" x2="1191.2" y2="1228.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-15  G22992A  Australia=161 [97.0%]  surface glycoprotein, S477N</title>
	<circle cx="1055.6" cy="1672.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  GGA23401AGG  Australia=2 [1.2%]  surface glycoprotein, D614G</title>
	<circle cx="1029.0" cy="1759.3" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A23403G  Australia=2 [1.2%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="1759.7" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  C23457A  Australia=6 [3.6%]  surface glycoprotein, T632N</title>
	<circle cx="1025.4" cy="1771.2" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  G24933T  Australia=2 [1.2%]  surface glycoprotein, G1124V</title>
	<circle cx="929.2" cy="2085.6" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16 Australia: 188 samples</title>
	<line x1="1193.8" y1="1219.0" x2="1190.7" y2="1228.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-16  G22992A  Australia=181 [96.3%]  surface glycoprotein, S477N</title>
	<circle cx="1047.4" cy="1669.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  GGA23401AGG  Australia=2 [1.1%]  surface glycoprotein, D614G</title>
	<circle cx="1019.3" cy="1756.2" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  A23403G  Australia=2 [1.1%]  surface glycoprotein, D614G</title>
	<circle cx="1019.1" cy="1756.7" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  C23457A  Australia=4 [2.1%]  surface glycoprotein, T632N</title>
	<circle cx="1015.4" cy="1768.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  C23895T  Australia=2 [1.1%]  surface glycoprotein, T778I</title>
	<circle cx="985.3" cy="1860.9" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  G24926T  Australia=4 [2.1%]  surface glycoprotein, V1122L</title>
	<circle cx="914.3" cy="2079.3" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17 Australia: 219 samples</title>
	<line x1="1193.5" y1="1218.9" x2="1190.1" y2="1228.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-17  C21774T  Australia=2 [0.9%]  surface glycoprotein, S71F</title>
	<circle cx="1127.6" cy="1410.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  G22992A  Australia=214 [97.7%]  surface glycoprotein, S477N</title>
	<circle cx="1039.2" cy="1666.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  GGA23401AGG  Australia=6 [2.7%]  surface glycoprotein, D614G</title>
	<circle cx="1009.6" cy="1753.0" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  A23403G  Australia=2 [0.9%]  surface glycoprotein, D614G</title>
	<circle cx="1009.4" cy="1753.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  C23457A  Australia=5 [2.3%]  surface glycoprotein, T632N</title>
	<circle cx="1005.5" cy="1764.8" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18 Australia: 271 samples</title>
	<line x1="1193.2" y1="1218.8" x2="1189.4" y2="1229.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-18  C22323T  Australia=2 [0.7%]  surface glycoprotein, S254F</title>
	<circle cx="1082.1" cy="1524.0" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  G22992A  Australia=266 [98.2%]  surface glycoprotein, S477N</title>
	<circle cx="1031.1" cy="1664.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  GGA23401AGG  Australia=9 [3.3%]  surface glycoprotein, D614G</title>
	<circle cx="1000.0" cy="1749.6" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  C23457A  Australia=11 [4.1%]  surface glycoprotein, T632N</title>
	<circle cx="995.7" cy="1761.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  C23895T  Australia=2 [0.7%]  surface glycoprotein, T778I</title>
	<circle cx="962.3" cy="1853.0" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19 Australia: 163 samples</title>
	<line x1="1192.8" y1="1218.7" x2="1189.3" y2="1228.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-19  G22992A  Australia=155 [95.1%]  surface glycoprotein, S477N</title>
	<circle cx="1023.1" cy="1661.0" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  GGA23401AGG  Australia=3 [1.8%]  surface glycoprotein, D614G</title>
	<circle cx="990.4" cy="1746.0" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  C23457A  Australia=5 [3.1%]  surface glycoprotein, T632N</title>
	<circle cx="985.9" cy="1757.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20 Australia: 223 samples</title>
	<line x1="1192.5" y1="1218.5" x2="1188.5" y2="1228.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-20 Papua New Guinea: 2 samples</title>
	<line x1="1188.5" y1="1228.3" x2="1187.7" y2="1230.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-20  C21575T  Australia=2 [0.9%]  surface glycoprotein, L5F</title>
	<circle cx="1133.3" cy="1365.2" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G21666T  Australia=2 [0.9%]  surface glycoprotein, G35V</title>
	<circle cx="1125.7" cy="1384.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  C22323T  Australia=2 [0.9%]  surface glycoprotein, S254F</title>
	<circle cx="1070.8" cy="1519.7" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G22992A  Australia=204 [91.5%]  surface glycoprotein, S477N</title>
	<circle cx="1015.0" cy="1657.8" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  GGA23401AGG  Australia=7 [3.1%]  surface glycoprotein, D614G</title>
	<circle cx="980.9" cy="1742.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  A23403G  Australia=4 [1.8%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="1742.7" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  C23439T  Australia=2 [0.9%]  surface glycoprotein, A626V</title>
	<circle cx="977.7" cy="1750.1" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  C23457A  Australia=9 [4.0%]  surface glycoprotein, T632N</title>
	<circle cx="976.2" cy="1753.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  C23895T  Australia=4 [1.8%]  surface glycoprotein, T778I</title>
	<circle cx="939.7" cy="1844.3" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G24764T  Australia=2 [0.9%]  surface glycoprotein, V1068F</title>
	<circle cx="867.2" cy="2023.7" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  G24933T  Australia=2 [0.9%]  surface glycoprotein, G1124V</title>
	<circle cx="853.1" cy="2058.6" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21 Australia: 249 samples</title>
	<line x1="1192.2" y1="1218.4" x2="1188.0" y2="1228.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21 Papua New Guinea: 3 samples</title>
	<line x1="1188.0" y1="1228.3" x2="1186.9" y2="1230.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21  G22992A  Australia=242 [97.2%]  surface glycoprotein, S477N</title>
	<circle cx="1007.1" cy="1654.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  GGA23401AGG  Australia=8 [3.2%]  surface glycoprotein, D614G</title>
	<circle cx="971.5" cy="1738.4" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A23403G  Australia=2 [0.8%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="1738.8" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  C23457A  Australia=5 [2.0%]  surface glycoprotein, T632N</title>
	<circle cx="966.6" cy="1749.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  C23895T  Australia=2 [0.8%]  surface glycoprotein, T778I</title>
	<circle cx="928.5" cy="1839.6" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  G24926T  Australia=2 [0.8%]  surface glycoprotein, V1122L</title>
	<circle cx="838.8" cy="2051.0" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  G24933T  Australia=3 [1.2%]  surface glycoprotein, G1124V</title>
	<circle cx="838.2" cy="2052.4" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22 Australia: 214 samples</title>
	<line x1="1191.9" y1="1218.3" x2="1187.6" y2="1227.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-22  C22323T  Australia=2 [0.9%]  surface glycoprotein, S254F</title>
	<circle cx="1059.8" cy="1515.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  G22992A  Australia=201 [93.9%]  surface glycoprotein, S477N</title>
	<circle cx="999.2" cy="1651.1" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  GGA23401AGG  Australia=10 [4.7%]  surface glycoprotein, D614G</title>
	<circle cx="962.1" cy="1734.3" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  A23403G  Australia=2 [0.9%]  surface glycoprotein, D614G</title>
	<circle cx="961.9" cy="1734.7" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  C23457A  Australia=16 [7.5%]  surface glycoprotein, T632N</title>
	<circle cx="957.0" cy="1745.7" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  G23593T  Australia=2 [0.9%]  surface glycoprotein, Q677H</title>
	<circle cx="944.7" cy="1773.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  G24933T  Australia=10 [4.7%]  surface glycoprotein, G1124V</title>
	<circle cx="823.3" cy="2046.0" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23 Australia: 344 samples</title>
	<line x1="1191.5" y1="1218.1" x2="1186.7" y2="1228.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-23  G22992A  Australia=327 [95.1%]  surface glycoprotein, S477N</title>
	<circle cx="991.3" cy="1647.5" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  GGA23401AGG  Australia=17 [4.9%]  surface glycoprotein, D614G</title>
	<circle cx="952.8" cy="1730.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  C23457A  Australia=5 [1.5%]  surface glycoprotein, T632N</title>
	<circle cx="947.6" cy="1741.4" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  C23613T  Australia=3 [0.9%]  surface glycoprotein, A684V</title>
	<circle cx="932.9" cy="1772.9" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23  G24933T  Australia=10 [2.9%]  surface glycoprotein, G1124V</title>
	<circle cx="808.6" cy="2039.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24 Australia: 225 samples</title>
	<line x1="1191.2" y1="1218.0" x2="1186.6" y2="1227.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-24  G21666T  Australia=2 [0.9%]  surface glycoprotein, G35V</title>
	<circle cx="1113.0" cy="1378.4" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  T22328C  Australia=2 [0.9%]  surface glycoprotein, S256P</title>
	<circle cx="1048.4" cy="1510.9" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  G22992A  Australia=217 [96.4%]  surface glycoprotein, S477N</title>
	<circle cx="983.5" cy="1643.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  GGA23401AGG  Australia=16 [7.1%]  surface glycoprotein, D614G</title>
	<circle cx="943.6" cy="1725.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  A23403G  Australia=2 [0.9%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="1726.1" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  C23457A  Australia=5 [2.2%]  surface glycoprotein, T632N</title>
	<circle cx="938.1" cy="1736.9" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  C23655T  Australia=2 [0.9%]  surface glycoprotein, S698L</title>
	<circle cx="918.8" cy="1776.5" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  G24764T  Australia=5 [2.2%]  surface glycoprotein, V1068F</title>
	<circle cx="810.5" cy="1998.5" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25 Australia: 201 samples</title>
	<line x1="1190.9" y1="1217.8" x2="1186.2" y2="1227.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-25  G22992A  Australia=197 [98.0%]  surface glycoprotein, S477N</title>
	<circle cx="975.8" cy="1639.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25  GGA23401AGG  Australia=16 [8.0%]  surface glycoprotein, D614G</title>
	<circle cx="934.5" cy="1721.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25  C23457A  Australia=6 [3.0%]  surface glycoprotein, T632N</title>
	<circle cx="928.8" cy="1732.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25  C23655T  Australia=2 [1.0%]  surface glycoprotein, S698L</title>
	<circle cx="908.8" cy="1771.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25  G24764T  Australia=4 [2.0%]  surface glycoprotein, V1068F</title>
	<circle cx="796.7" cy="1991.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-26 Australia: 115 samples</title>
	<line x1="1190.6" y1="1217.7" x2="1186.2" y2="1225.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-26  G22992A  Australia=110 [95.7%]  surface glycoprotein, S477N</title>
	<circle cx="968.2" cy="1636.0" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-26  GGA23401AGG  Australia=5 [4.3%]  surface glycoprotein, D614G</title>
	<circle cx="925.4" cy="1716.4" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-26  C23457A  Australia=6 [5.2%]  surface glycoprotein, T632N</title>
	<circle cx="919.6" cy="1727.4" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-26  G24764T  Australia=3 [2.6%]  surface glycoprotein, V1068F</title>
	<circle cx="782.9" cy="1984.4" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27 Australia: 283 samples</title>
	<line x1="1190.3" y1="1217.5" x2="1185.0" y2="1227.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-27  C22323T  Australia=2 [0.7%]  surface glycoprotein, S254F</title>
	<circle cx="1032.9" cy="1501.5" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G22992A  Australia=267 [94.3%]  surface glycoprotein, S477N</title>
	<circle cx="960.6" cy="1631.9" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  GGA23401AGG  Australia=17 [6.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.5" cy="1711.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  A23403G  Australia=2 [0.7%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="1711.9" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  C23457A  Australia=13 [4.6%]  surface glycoprotein, T632N</title>
	<circle cx="910.4" cy="1722.4" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  C24579T  Australia=2 [0.7%]  surface glycoprotein, T1006I</title>
	<circle cx="789.3" cy="1941.0" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G24764T  Australia=2 [0.7%]  surface glycoprotein, V1068F</title>
	<circle cx="769.3" cy="1977.0" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28 Australia: 279 samples</title>
	<line x1="1190.0" y1="1217.3" x2="1184.5" y2="1226.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-28  C21575T  Australia=2 [0.7%]  surface glycoprotein, L5F</title>
	<circle cx="1110.9" cy="1354.3" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  C22323T  Australia=3 [1.1%]  surface glycoprotein, S254F</title>
	<circle cx="1027.6" cy="1498.6" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G22992A  Australia=260 [93.2%]  surface glycoprotein, S477N</title>
	<circle cx="953.1" cy="1627.6" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  GGA23401AGG  Australia=16 [5.7%]  surface glycoprotein, D614G</title>
	<circle cx="907.6" cy="1706.5" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  A23403G  Australia=3 [1.1%]  surface glycoprotein, D614G</title>
	<circle cx="907.3" cy="1706.9" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  C23457A  Australia=3 [1.1%]  surface glycoprotein, T632N</title>
	<circle cx="901.3" cy="1717.3" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  C23655T  Australia=3 [1.1%]  surface glycoprotein, S698L</title>
	<circle cx="879.3" cy="1755.5" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  G24764T  Australia=2 [0.7%]  surface glycoprotein, V1068F</title>
	<circle cx="755.8" cy="1969.4" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29 Australia: 270 samples</title>
	<line x1="1189.7" y1="1217.1" x2="1184.1" y2="1226.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-29  C21575T  Australia=3 [1.1%]  surface glycoprotein, L5F</title>
	<circle cx="1108.2" cy="1352.7" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  C22227T  Australia=2 [0.7%]  surface glycoprotein, A222V</title>
	<circle cx="1033.4" cy="1477.2" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  G22992A  Australia=259 [95.9%]  surface glycoprotein, S477N</title>
	<circle cx="945.7" cy="1623.2" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  GGA23401AGG  Australia=10 [3.7%]  surface glycoprotein, D614G</title>
	<circle cx="898.8" cy="1701.3" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  C23457A  Australia=14 [5.2%]  surface glycoprotein, T632N</title>
	<circle cx="892.4" cy="1712.0" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  C23655T  Australia=2 [0.7%]  surface glycoprotein, S698L</title>
	<circle cx="869.6" cy="1749.8" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  G24764T  Australia=4 [1.5%]  surface glycoprotein, V1068F</title>
	<circle cx="742.4" cy="1961.5" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30 Australia: 204 samples</title>
	<line x1="1189.4" y1="1217.0" x2="1183.9" y2="1225.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-30  C21575T  Australia=3 [1.5%]  surface glycoprotein, L5F</title>
	<circle cx="1105.6" cy="1351.1" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  C22323T  Australia=2 [1.0%]  surface glycoprotein, S254F</title>
	<circle cx="1017.3" cy="1492.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  G22992A  Australia=196 [96.1%]  surface glycoprotein, S477N</title>
	<circle cx="938.3" cy="1618.7" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  GGA23401AGG  Australia=13 [6.4%]  surface glycoprotein, D614G</title>
	<circle cx="890.1" cy="1696.0" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  C23457A  Australia=3 [1.5%]  surface glycoprotein, T632N</title>
	<circle cx="883.5" cy="1706.6" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  C23655T  Australia=2 [1.0%]  surface glycoprotein, S698L</title>
	<circle cx="860.1" cy="1744.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  G24764T  Australia=5 [2.5%]  surface glycoprotein, V1068F</title>
	<circle cx="729.2" cy="1953.4" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31 Australia: 173 samples</title>
	<line x1="1189.1" y1="1216.8" x2="1183.6" y2="1225.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-31  C22323T  Australia=5 [2.9%]  surface glycoprotein, S254F</title>
	<circle cx="1012.2" cy="1489.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G22992A  Australia=164 [94.8%]  surface glycoprotein, S477N</title>
	<circle cx="931.1" cy="1614.1" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  GGA23401AGG  Australia=10 [5.8%]  surface glycoprotein, D614G</title>
	<circle cx="881.5" cy="1690.5" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  A23403G  Australia=2 [1.2%]  surface glycoprotein, D614G</title>
	<circle cx="881.2" cy="1690.9" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  C23655T  Australia=5 [2.9%]  surface glycoprotein, S698L</title>
	<circle cx="850.7" cy="1737.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G24102C  Australia=5 [2.9%]  surface glycoprotein, R847T</title>
	<circle cx="796.4" cy="1821.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  C24351T  Australia=4 [2.3%]  surface glycoprotein, A930V</title>
	<circle cx="766.2" cy="1867.9" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G24764T  Australia=3 [1.7%]  surface glycoprotein, V1068F</title>
	<circle cx="716.1" cy="1945.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31  G24992C  Australia=2 [1.2%]  surface glycoprotein, E1144Q</title>
	<circle cx="688.5" cy="1987.7" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01 Australia: 172 samples</title>
	<line x1="1188.8" y1="1216.6" x2="1183.2" y2="1224.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-01  C22323T  Australia=2 [1.2%]  surface glycoprotein, S254F</title>
	<circle cx="1007.2" cy="1485.8" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  G22992A  Australia=156 [90.7%]  surface glycoprotein, S477N</title>
	<circle cx="923.9" cy="1609.3" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  GGA23401AGG  Australia=11 [6.4%]  surface glycoprotein, D614G</title>
	<circle cx="873.0" cy="1684.9" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  A23403G  Australia=2 [1.2%]  surface glycoprotein, D614G</title>
	<circle cx="872.7" cy="1685.2" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  C23457A  Australia=6 [3.5%]  surface glycoprotein, T632N</title>
	<circle cx="866.0" cy="1695.2" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  C23655T  Australia=5 [2.9%]  surface glycoprotein, S698L</title>
	<circle cx="841.3" cy="1731.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  C24351T  Australia=19 [11.0%]  surface glycoprotein, A930V</title>
	<circle cx="754.6" cy="1860.3" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  C24897T  Australia=3 [1.7%]  surface glycoprotein, P1112L</title>
	<circle cx="686.6" cy="1961.1" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01  G24992C  Australia=3 [1.7%]  surface glycoprotein, E1144Q</title>
	<circle cx="674.8" cy="1978.6" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02 Australia: 193 samples</title>
	<line x1="1188.5" y1="1216.4" x2="1182.6" y2="1224.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-02  C22323T  Australia=4 [2.1%]  surface glycoprotein, S254F</title>
	<circle cx="1002.3" cy="1482.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  G22992A  Australia=173 [89.6%]  surface glycoprotein, S477N</title>
	<circle cx="916.8" cy="1604.5" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  GGA23401AGG  Australia=11 [5.7%]  surface glycoprotein, D614G</title>
	<circle cx="864.5" cy="1679.1" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  C23457A  Australia=4 [2.1%]  surface glycoprotein, T632N</title>
	<circle cx="857.4" cy="1689.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  C23655T  Australia=2 [1.0%]  surface glycoprotein, S698L</title>
	<circle cx="832.1" cy="1725.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  G24764T  Australia=6 [3.1%]  surface glycoprotein, V1068F</title>
	<circle cx="690.4" cy="1927.8" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02  C24912T  Australia=2 [1.0%]  surface glycoprotein, T1117I</title>
	<circle cx="671.5" cy="1954.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03 Australia: 226 samples</title>
	<line x1="1188.2" y1="1216.2" x2="1182.0" y2="1224.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-03  G22992A  Australia=203 [89.8%]  surface glycoprotein, S477N</title>
	<circle cx="909.8" cy="1599.5" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  GGA23401AGG  Australia=15 [6.6%]  surface glycoprotein, D614G</title>
	<circle cx="856.2" cy="1673.2" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  A23403G  Australia=4 [1.8%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="1673.5" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  C23457A  Australia=5 [2.2%]  surface glycoprotein, T632N</title>
	<circle cx="848.9" cy="1683.2" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  G24764T  Australia=3 [1.3%]  surface glycoprotein, V1068F</title>
	<circle cx="677.8" cy="1918.7" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  C24912T  Australia=4 [1.8%]  surface glycoprotein, T1117I</title>
	<circle cx="658.4" cy="1945.4" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03  G24992C  Australia=2 [0.9%]  surface glycoprotein, E1144Q</title>
	<circle cx="648.0" cy="1959.8" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04 Australia: 194 samples</title>
	<line x1="1188.0" y1="1216.0" x2="1181.8" y2="1224.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-04  C21575T  Australia=2 [1.0%]  surface glycoprotein, L5F</title>
	<circle cx="1092.8" cy="1342.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  G22520A  Australia=2 [1.0%]  surface glycoprotein, V320I</title>
	<circle cx="966.1" cy="1510.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  G22992A  Australia=174 [89.7%]  surface glycoprotein, S477N</title>
	<circle cx="902.8" cy="1594.3" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  GGA23401AGG  Australia=11 [5.7%]  surface glycoprotein, D614G</title>
	<circle cx="848.0" cy="1667.1" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  C23457A  Australia=4 [2.1%]  surface glycoprotein, T632N</title>
	<circle cx="840.5" cy="1677.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  C23655T  Australia=2 [1.0%]  surface glycoprotein, S698L</title>
	<circle cx="814.0" cy="1712.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  C24351T  Australia=3 [1.5%]  surface glycoprotein, A930V</title>
	<circle cx="720.7" cy="1836.1" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  G24764T  Australia=3 [1.5%]  surface glycoprotein, V1068F</title>
	<circle cx="665.3" cy="1909.5" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  G24992C  Australia=3 [1.5%]  surface glycoprotein, E1144Q</title>
	<circle cx="634.8" cy="1950.1" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05 Australia: 146 samples</title>
	<line x1="1187.7" y1="1215.8" x2="1181.7" y2="1223.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-05  C22323T  Australia=2 [1.4%]  surface glycoprotein, S254F</title>
	<circle cx="987.7" cy="1471.7" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  G22992A  Australia=130 [89.0%]  surface glycoprotein, S477N</title>
	<circle cx="896.0" cy="1589.1" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  GGA23401AGG  Australia=8 [5.5%]  surface glycoprotein, D614G</title>
	<circle cx="839.9" cy="1660.9" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  C23457A  Australia=3 [2.1%]  surface glycoprotein, T632N</title>
	<circle cx="832.2" cy="1670.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  C24351T  Australia=2 [1.4%]  surface glycoprotein, A930V</title>
	<circle cx="709.7" cy="1827.6" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05  G24764T  Australia=3 [2.1%]  surface glycoprotein, V1068F</title>
	<circle cx="653.0" cy="1900.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06 Australia: 210 samples</title>
	<line x1="1187.4" y1="1215.5" x2="1180.8" y2="1223.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-06  C21575T  Australia=3 [1.4%]  surface glycoprotein, L5F</title>
	<circle cx="1087.9" cy="1338.5" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C22323T  Australia=2 [1.0%]  surface glycoprotein, S254F</title>
	<circle cx="983.0" cy="1467.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G22992A  Australia=190 [90.5%]  surface glycoprotein, S477N</title>
	<circle cx="889.3" cy="1583.7" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  GGA23401AGG  Australia=19 [9.0%]  surface glycoprotein, D614G</title>
	<circle cx="831.9" cy="1654.5" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C23457A  Australia=5 [2.4%]  surface glycoprotein, T632N</title>
	<circle cx="824.1" cy="1664.2" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C23655T  Australia=3 [1.4%]  surface glycoprotein, S698L</title>
	<circle cx="796.3" cy="1698.5" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G24764T  Australia=4 [1.9%]  surface glycoprotein, V1068F</title>
	<circle cx="640.9" cy="1890.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  C24897T  Australia=4 [1.9%]  surface glycoprotein, P1112L</title>
	<circle cx="622.3" cy="1913.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06  G24992C  Australia=13 [6.2%]  surface glycoprotein, E1144Q</title>
	<circle cx="608.9" cy="1929.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07 Australia: 111 samples</title>
	<line x1="1187.1" y1="1215.3" x2="1181.2" y2="1222.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-07  C21575T  Australia=3 [2.7%]  surface glycoprotein, L5F</title>
	<circle cx="1085.5" cy="1336.5" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  C22323T  Australia=2 [1.8%]  surface glycoprotein, S254F</title>
	<circle cx="978.4" cy="1464.1" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  G22992A  Australia=102 [91.9%]  surface glycoprotein, S477N</title>
	<circle cx="882.6" cy="1578.2" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  GGA23401AGG  Australia=7 [6.3%]  surface glycoprotein, D614G</title>
	<circle cx="824.1" cy="1648.0" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  C24351T  Australia=2 [1.8%]  surface glycoprotein, A930V</title>
	<circle cx="688.1" cy="1810.1" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  G24764T  Australia=2 [1.8%]  surface glycoprotein, V1068F</title>
	<circle cx="628.9" cy="1880.6" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07  G25290T  Australia=2 [1.8%]  surface glycoprotein, C1243F</title>
	<circle cx="553.6" cy="1970.3" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08 Australia: 94 samples</title>
	<line x1="1186.9" y1="1215.1" x2="1181.0" y2="1221.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-08  G22992A  Australia=81 [86.2%]  surface glycoprotein, S477N</title>
	<circle cx="876.1" cy="1572.6" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  G23311T  Australia=3 [3.2%]  surface glycoprotein, E583D</title>
	<circle cx="829.5" cy="1626.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  GGA23401AGG  Australia=6 [6.4%]  surface glycoprotein, D614G</title>
	<circle cx="816.3" cy="1641.4" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  A23403G  Australia=3 [3.2%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="1641.7" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  C24351T  Australia=2 [2.1%]  surface glycoprotein, A930V</title>
	<circle cx="677.5" cy="1801.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  C24912T  Australia=4 [4.3%]  surface glycoprotein, T1117I</title>
	<circle cx="595.5" cy="1895.4" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  C25460T  Australia=2 [2.1%]  ORF3a protein, A23V</title>
	<circle cx="515.4" cy="1987.5" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09 Australia: 104 samples</title>
	<line x1="1186.6" y1="1214.9" x2="1180.5" y2="1221.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-09  G22520A  Australia=2 [1.9%]  surface glycoprotein, V320I</title>
	<circle cx="939.9" cy="1488.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  G22992A  Australia=92 [88.5%]  surface glycoprotein, S477N</title>
	<circle cx="869.6" cy="1566.9" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  GGA23401AGG  Australia=6 [5.8%]  surface glycoprotein, D614G</title>
	<circle cx="808.7" cy="1634.6" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  C23457A  Australia=2 [1.9%]  surface glycoprotein, T632N</title>
	<circle cx="800.3" cy="1643.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  C23655T  Australia=6 [5.8%]  surface glycoprotein, S698L</title>
	<circle cx="770.8" cy="1676.7" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  C24351T  Australia=2 [1.9%]  surface glycoprotein, A930V</title>
	<circle cx="667.1" cy="1791.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-09  G24992C  Australia=2 [1.9%]  surface glycoprotein, E1144Q</title>
	<circle cx="571.6" cy="1898.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10 Australia: 109 samples</title>
	<line x1="1186.4" y1="1214.6" x2="1180.1" y2="1221.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-10  G22520A  Australia=2 [1.8%]  surface glycoprotein, V320I</title>
	<circle cx="934.9" cy="1484.2" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G22992A  Australia=102 [93.6%]  surface glycoprotein, S477N</title>
	<circle cx="863.3" cy="1561.1" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  GGA23401AGG  Australia=6 [5.5%]  surface glycoprotein, D614G</title>
	<circle cx="801.1" cy="1627.7" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  C23457A  Australia=2 [1.8%]  surface glycoprotein, T632N</title>
	<circle cx="792.6" cy="1636.9" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  C23655T  Australia=4 [3.7%]  surface glycoprotein, S698L</title>
	<circle cx="762.5" cy="1669.1" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G24764T  Australia=2 [1.8%]  surface glycoprotein, V1068F</title>
	<circle cx="594.1" cy="1849.7" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G24992C  Australia=3 [2.8%]  surface glycoprotein, E1144Q</title>
	<circle cx="559.5" cy="1886.9" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-10  G25290T  Australia=2 [1.8%]  surface glycoprotein, C1243F</title>
	<circle cx="514.2" cy="1935.4" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11 Australia: 112 samples</title>
	<line x1="1186.1" y1="1214.4" x2="1179.7" y2="1221.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-11  G21800T  Australia=3 [2.7%]  surface glycoprotein, D80Y</title>
	<circle cx="1041.4" cy="1364.2" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  G22992A  Australia=99 [88.4%]  surface glycoprotein, S477N</title>
	<circle cx="857.0" cy="1555.2" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  GGA23401AGG  Australia=6 [5.4%]  surface glycoprotein, D614G</title>
	<circle cx="793.7" cy="1620.7" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  A23403G  Australia=4 [3.6%]  surface glycoprotein, D614G</title>
	<circle cx="793.4" cy="1621.0" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  C23457A  Australia=2 [1.8%]  surface glycoprotein, T632N</title>
	<circle cx="785.1" cy="1629.7" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  C23655T  Australia=3 [2.7%]  surface glycoprotein, S698L</title>
	<circle cx="754.4" cy="1661.4" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  G24764T  Australia=2 [1.8%]  surface glycoprotein, V1068F</title>
	<circle cx="582.9" cy="1839.1" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11  C24912T  Australia=3 [2.7%]  surface glycoprotein, T1117I</title>
	<circle cx="560.0" cy="1862.8" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12 Australia: 127 samples</title>
	<line x1="1185.9" y1="1214.1" x2="1179.2" y2="1220.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-12  G21800T  Australia=2 [1.6%]  surface glycoprotein, D80Y</title>
	<circle cx="1038.6" cy="1361.4" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  G22520A  Australia=3 [2.4%]  surface glycoprotein, V320I</title>
	<circle cx="925.2" cy="1474.8" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  G22992A  Australia=116 [91.3%]  surface glycoprotein, S477N</title>
	<circle cx="850.9" cy="1549.1" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  GGA23401AGG  Australia=9 [7.1%]  surface glycoprotein, D614G</title>
	<circle cx="786.4" cy="1613.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  C23457A  Australia=5 [3.9%]  surface glycoprotein, T632N</title>
	<circle cx="777.6" cy="1622.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  G24764T  Australia=6 [4.7%]  surface glycoprotein, V1068F</title>
	<circle cx="571.8" cy="1828.2" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12  C24912T  Australia=3 [2.4%]  surface glycoprotein, T1117I</title>
	<circle cx="548.5" cy="1851.5" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13 Australia: 122 samples</title>
	<line x1="1185.6" y1="1213.9" x2="1178.8" y2="1220.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-13 New Zealand: 8 samples</title>
	<line x1="1178.8" y1="1220.4" x2="1175.8" y2="1223.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-13  C22227T  Australia=2 [1.6%]  surface glycoprotein, A222V</title>
	<circle cx="967.4" cy="1424.6" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  G22992A  Australia=110 [90.2%]  surface glycoprotein, S477N</title>
	<circle cx="844.8" cy="1543.0" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  G23311T  Australia=2 [1.6%]  surface glycoprotein, E583D</title>
	<circle cx="793.7" cy="1592.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  GGA23401AGG  Australia=6 [4.9%]  surface glycoprotein, D614G</title>
	<circle cx="779.3" cy="1606.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  A23403G  New Zealand=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="779.0" cy="1606.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  C23655T  Australia=2 [1.6%]  surface glycoprotein, S698L</title>
	<circle cx="738.6" cy="1645.6" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  G25244T  Australia=2 [1.6%]  surface glycoprotein, V1228L</title>
	<circle cx="484.0" cy="1891.4" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14 Australia: 108 samples</title>
	<line x1="1185.4" y1="1213.6" x2="1178.7" y2="1219.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-14 New Zealand: 6 samples</title>
	<line x1="1178.7" y1="1219.9" x2="1175.9" y2="1222.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-14  G22520A  Australia=2 [1.9%]  surface glycoprotein, V320I</title>
	<circle cx="915.8" cy="1465.1" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  G22992A  Australia=93 [86.1%]  surface glycoprotein, S477N</title>
	<circle cx="838.9" cy="1536.7" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  GGA23401AGG  Australia=3 [2.8%]  surface glycoprotein, D614G</title>
	<circle cx="772.3" cy="1598.9" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  A23403G  New Zealand=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="1599.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  C23655T  Australia=5 [4.6%]  surface glycoprotein, S698L</title>
	<circle cx="730.9" cy="1637.5" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  C24351T  Australia=2 [1.9%]  surface glycoprotein, A930V</title>
	<circle cx="617.5" cy="1743.2" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  G24764T  Australia=3 [2.8%]  surface glycoprotein, V1068F</title>
	<circle cx="550.3" cy="1805.9" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  C24897T  Australia=3 [2.8%]  surface glycoprotein, P1112L</title>
	<circle cx="528.6" cy="1826.1" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15 Australia: 84 samples</title>
	<line x1="1185.1" y1="1213.4" x2="1178.7" y2="1219.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-15 New Zealand: 2 samples</title>
	<line x1="1178.7" y1="1219.2" x2="1177.1" y2="1220.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-15  G21800T  Australia=2 [2.4%]  surface glycoprotein, D80Y</title>
	<circle cx="1030.4" cy="1352.8" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  C22227T  Australia=3 [3.6%]  surface glycoprotein, A222V</title>
	<circle cx="959.7" cy="1416.4" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  C22323T  Australia=2 [2.4%]  surface glycoprotein, S254F</title>
	<circle cx="943.8" cy="1430.7" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  G22992A  Australia=68 [81.0%]  surface glycoprotein, S477N</title>
	<circle cx="833.1" cy="1530.4" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  GGA23401AGG  Australia=4 [4.8%]  surface glycoprotein, D614G</title>
	<circle cx="765.4" cy="1591.3" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="765.0" cy="1591.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  A23403G  Australia=3 [3.6%]  surface glycoprotein, D614G</title>
	<circle cx="765.0" cy="1591.6" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  C23655T  Australia=7 [8.3%]  surface glycoprotein, S698L</title>
	<circle cx="723.3" cy="1629.2" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  G24764T  Australia=2 [2.4%]  surface glycoprotein, V1068F</title>
	<circle cx="539.8" cy="1794.5" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  A25137C  Australia=4 [4.8%]  surface glycoprotein, N1192T</title>
	<circle cx="478.0" cy="1850.1" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16 Australia: 82 samples</title>
	<line x1="1184.9" y1="1213.1" x2="1178.4" y2="1218.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-16 New Zealand: 4 samples</title>
	<line x1="1178.4" y1="1218.8" x2="1176.0" y2="1220.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-16  G22520A  Australia=2 [2.4%]  surface glycoprotein, V320I</title>
	<circle cx="906.7" cy="1455.0" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  G22992A  Australia=75 [91.5%]  surface glycoprotein, S477N</title>
	<circle cx="827.4" cy="1523.9" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  G23311T  Australia=2 [2.4%]  surface glycoprotein, E583D</title>
	<circle cx="773.7" cy="1570.5" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  GGA23401AGG  Australia=8 [9.8%]  surface glycoprotein, D614G</title>
	<circle cx="758.6" cy="1583.7" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  A23403G  New Zealand=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="1584.0" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  C23457A  Australia=2 [2.4%]  surface glycoprotein, T632N</title>
	<circle cx="749.2" cy="1591.9" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  C23655T  Australia=3 [3.7%]  surface glycoprotein, S698L</title>
	<circle cx="715.9" cy="1620.8" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  C24026T  Australia=2 [2.4%]  surface glycoprotein, L822F</title>
	<circle cx="653.5" cy="1675.0" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16  C24351T  Australia=2 [2.4%]  surface glycoprotein, A930V</title>
	<circle cx="598.9" cy="1722.5" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17 Australia: 126 samples</title>
	<line x1="1184.7" y1="1212.9" x2="1177.4" y2="1218.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-17 New Zealand: 4 samples</title>
	<line x1="1177.4" y1="1218.9" x2="1175.0" y2="1221.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-17  C22227T  Australia=4 [3.2%]  surface glycoprotein, A222V</title>
	<circle cx="952.3" cy="1407.9" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G22520A  Australia=5 [4.0%]  surface glycoprotein, V320I</title>
	<circle cx="902.3" cy="1449.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G22992A  Australia=118 [93.7%]  surface glycoprotein, S477N</title>
	<circle cx="821.8" cy="1517.4" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  GGA23401AGG  Australia=14 [11.1%]  surface glycoprotein, D614G</title>
	<circle cx="752.0" cy="1575.9" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A23403G  New Zealand=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="1576.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  C23457A  Australia=4 [3.2%]  surface glycoprotein, T632N</title>
	<circle cx="742.4" cy="1584.0" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  C23655T  Australia=4 [3.2%]  surface glycoprotein, S698L</title>
	<circle cx="708.6" cy="1612.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  C24026T  Australia=3 [2.4%]  surface glycoprotein, L822F</title>
	<circle cx="645.3" cy="1665.4" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  C24351T  Australia=2 [1.6%]  surface glycoprotein, A930V</title>
	<circle cx="589.9" cy="1711.9" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G24764T  Australia=2 [1.6%]  surface glycoprotein, V1068F</title>
	<circle cx="519.4" cy="1771.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  C24897T  Australia=2 [1.6%]  surface glycoprotein, P1112L</title>
	<circle cx="496.7" cy="1790.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  G24992C  Australia=2 [1.6%]  surface glycoprotein, E1144Q</title>
	<circle cx="480.5" cy="1803.7" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A25137C  Australia=2 [1.6%]  surface glycoprotein, N1192T</title>
	<circle cx="455.8" cy="1824.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18 Australia: 87 samples</title>
	<line x1="1184.5" y1="1212.6" x2="1177.7" y2="1218.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-18 New Zealand: 3 samples</title>
	<line x1="1177.7" y1="1218.1" x2="1175.6" y2="1219.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-18  G21800T  Australia=2 [2.3%]  surface glycoprotein, D80Y</title>
	<circle cx="1022.6" cy="1343.7" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  G22992A  Australia=76 [87.4%]  surface glycoprotein, S477N</title>
	<circle cx="816.3" cy="1510.7" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  GGA23401AGG  Australia=7 [8.0%]  surface glycoprotein, D614G</title>
	<circle cx="745.5" cy="1568.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="745.1" cy="1568.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  C24351T  Australia=4 [4.6%]  surface glycoprotein, A930V</title>
	<circle cx="581.1" cy="1701.2" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  G24992C  Australia=2 [2.3%]  surface glycoprotein, E1144Q</title>
	<circle cx="470.1" cy="1791.1" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19 Australia: 94 samples</title>
	<line x1="1184.2" y1="1212.3" x2="1177.2" y2="1217.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-19 New Zealand: 5 samples</title>
	<line x1="1177.2" y1="1217.8" x2="1174.5" y2="1219.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-19  G22520A  Australia=4 [4.3%]  surface glycoprotein, V320I</title>
	<circle cx="893.7" cy="1439.3" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  G22992A  Australia=83 [88.3%]  surface glycoprotein, S477N</title>
	<circle cx="810.9" cy="1504.0" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  GGA23401AGG  Australia=7 [7.4%]  surface glycoprotein, D614G</title>
	<circle cx="739.1" cy="1560.1" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  A23403G  New Zealand=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="1560.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  A23403G  Australia=4 [4.3%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="1560.3" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  C23457A  Australia=5 [5.3%]  surface glycoprotein, T632N</title>
	<circle cx="729.3" cy="1567.8" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  C23895T  Australia=2 [2.1%]  surface glycoprotein, T778I</title>
	<circle cx="652.4" cy="1627.8" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  C24026T  Australia=4 [4.3%]  surface glycoprotein, L822F</title>
	<circle cx="629.4" cy="1645.8" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  C24351T  Australia=3 [3.2%]  surface glycoprotein, A930V</title>
	<circle cx="572.4" cy="1690.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19  G24764T  Australia=2 [2.1%]  surface glycoprotein, V1068F</title>
	<circle cx="499.9" cy="1747.0" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20 Australia: 99 samples</title>
	<line x1="1184.0" y1="1212.0" x2="1176.8" y2="1217.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-20  G21666T  Australia=5 [5.1%]  surface glycoprotein, G35V</title>
	<circle cx="1041.5" cy="1319.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  T21738C  Australia=2 [2.0%]  surface glycoprotein, F59S</title>
	<circle cx="1028.7" cy="1329.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  C22227T  Australia=3 [3.0%]  surface glycoprotein, A222V</title>
	<circle cx="941.7" cy="1394.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  G22992A  Australia=80 [80.8%]  surface glycoprotein, S477N</title>
	<circle cx="805.7" cy="1497.2" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  GGA23401AGG  Australia=4 [4.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.9" cy="1552.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  C23655T  Australia=4 [4.0%]  surface glycoprotein, S698L</title>
	<circle cx="687.7" cy="1586.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  C23895T  Australia=4 [4.0%]  surface glycoprotein, T778I</title>
	<circle cx="645.0" cy="1618.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  G24257T  Australia=2 [2.0%]  surface glycoprotein, A899S</title>
	<circle cx="580.7" cy="1666.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  A25137C  Australia=2 [2.0%]  surface glycoprotein, N1192T</title>
	<circle cx="424.1" cy="1784.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21 Australia: 113 samples</title>
	<line x1="1183.8" y1="1211.8" x2="1176.3" y2="1217.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-21  C21767T  Australia=5 [4.4%]  surface glycoprotein, H69Y</title>
	<circle cx="1021.3" cy="1329.9" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G21800T  Australia=3 [2.7%]  surface glycoprotein, D80Y</title>
	<circle cx="1015.3" cy="1334.2" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C22227T  Australia=3 [2.7%]  surface glycoprotein, A222V</title>
	<circle cx="938.4" cy="1390.1" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G22520A  Australia=3 [2.7%]  surface glycoprotein, V320I</title>
	<circle cx="885.6" cy="1428.4" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G22992A  Australia=101 [89.4%]  surface glycoprotein, S477N</title>
	<circle cx="800.5" cy="1490.2" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  GGA23401AGG  Australia=5 [4.4%]  surface glycoprotein, D614G</title>
	<circle cx="726.8" cy="1543.8" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  A23403G  Australia=2 [1.8%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="1544.0" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C23457A  Australia=2 [1.8%]  surface glycoprotein, T632N</title>
	<circle cx="716.8" cy="1551.1" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C23655T  Australia=6 [5.3%]  surface glycoprotein, S698L</title>
	<circle cx="681.1" cy="1577.0" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C24026T  Australia=2 [1.8%]  surface glycoprotein, L822F</title>
	<circle cx="614.2" cy="1625.6" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C24351T  Australia=5 [4.4%]  surface glycoprotein, A930V</title>
	<circle cx="555.7" cy="1668.1" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22 Australia: 58 samples</title>
	<line x1="1183.6" y1="1211.5" x2="1177.1" y2="1216.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-22  G21800T  Australia=2 [3.4%]  surface glycoprotein, D80Y</title>
	<circle cx="1013.0" cy="1330.9" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  G22992A  Australia=49 [84.5%]  surface glycoprotein, S477N</title>
	<circle cx="795.5" cy="1483.2" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  GGA23401AGG  Australia=3 [5.2%]  surface glycoprotein, D614G</title>
	<circle cx="720.9" cy="1535.5" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  A23403G  Australia=4 [6.9%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="1535.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  C23634T  Australia=2 [3.4%]  surface glycoprotein, S691F</title>
	<circle cx="678.4" cy="1565.2" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  C23655T  Australia=3 [5.2%]  surface glycoprotein, S698L</title>
	<circle cx="674.6" cy="1567.9" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  C23895T  Australia=2 [3.4%]  surface glycoprotein, T778I</title>
	<circle cx="630.8" cy="1598.6" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  C24351T  Australia=4 [6.9%]  surface glycoprotein, A930V</title>
	<circle cx="547.6" cy="1656.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22  G25244T  Australia=2 [3.4%]  surface glycoprotein, V1228L</title>
	<circle cx="384.7" cy="1770.9" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23 Australia: 60 samples</title>
	<line x1="1183.4" y1="1211.2" x2="1176.8" y2="1215.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-23 New Zealand: 3 samples</title>
	<line x1="1176.8" y1="1215.7" x2="1174.5" y2="1217.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-23  C21767T  Australia=4 [6.7%]  surface glycoprotein, H69Y</title>
	<circle cx="1016.8" cy="1323.5" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  G22992A  Australia=55 [91.7%]  surface glycoprotein, S477N</title>
	<circle cx="790.7" cy="1476.1" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  GGA23401AGG  Australia=7 [11.7%]  surface glycoprotein, D614G</title>
	<circle cx="715.1" cy="1527.0" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="714.8" cy="1527.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  C24351T  Australia=2 [3.3%]  surface glycoprotein, A930V</title>
	<circle cx="539.7" cy="1645.4" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  G24992C  Australia=2 [3.3%]  surface glycoprotein, E1144Q</title>
	<circle cx="421.4" cy="1725.2" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24 Australia: 95 samples</title>
	<line x1="1183.2" y1="1210.9" x2="1175.7" y2="1215.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-24 New Zealand: 2 samples</title>
	<line x1="1175.7" y1="1215.8" x2="1173.9" y2="1216.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-24  C22227T  Australia=2 [2.1%]  surface glycoprotein, A222V</title>
	<circle cx="928.8" cy="1376.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G22520A  Australia=2 [2.1%]  surface glycoprotein, V320I</title>
	<circle cx="874.1" cy="1411.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G22992A  Australia=84 [88.4%]  surface glycoprotein, S477N</title>
	<circle cx="785.9" cy="1468.9" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  GGA23401AGG  Australia=3 [3.2%]  surface glycoprotein, D614G</title>
	<circle cx="709.5" cy="1518.5" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="1518.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  C23457A  Australia=2 [2.1%]  surface glycoprotein, T632N</title>
	<circle cx="699.0" cy="1525.3" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  C23655T  Australia=4 [4.2%]  surface glycoprotein, S698L</title>
	<circle cx="662.1" cy="1549.3" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  C24026T  Australia=3 [3.2%]  surface glycoprotein, L822F</title>
	<circle cx="592.8" cy="1594.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  C24351T  Australia=4 [4.2%]  surface glycoprotein, A930V</title>
	<circle cx="532.1" cy="1633.8" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G24764T  Australia=7 [7.4%]  surface glycoprotein, V1068F</title>
	<circle cx="454.9" cy="1683.9" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  G24992C  Australia=3 [3.2%]  surface glycoprotein, E1144Q</title>
	<circle cx="412.3" cy="1711.5" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25 Australia: 59 samples</title>
	<line x1="1183.0" y1="1210.6" x2="1176.3" y2="1214.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-25 New Zealand: 3 samples</title>
	<line x1="1176.3" y1="1214.8" x2="1174.0" y2="1216.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-25  G21800T  Australia=3 [5.1%]  surface glycoprotein, D80Y</title>
	<circle cx="1006.4" cy="1321.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  G22992A  Australia=57 [96.6%]  surface glycoprotein, S477N</title>
	<circle cx="781.3" cy="1461.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="703.6" cy="1510.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  C23457A  Australia=3 [5.1%]  surface glycoprotein, T632N</title>
	<circle cx="693.4" cy="1516.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  C24026T  Australia=3 [5.1%]  surface glycoprotein, L822F</title>
	<circle cx="586.0" cy="1583.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  G24764T  Australia=6 [10.2%]  surface glycoprotein, V1068F</title>
	<circle cx="446.6" cy="1670.8" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26 Australia: 71 samples</title>
	<line x1="1182.9" y1="1210.3" x2="1175.7" y2="1214.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-26  G21800T  Australia=5 [7.0%]  surface glycoprotein, D80Y</title>
	<circle cx="1004.3" cy="1317.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  G22520A  Australia=2 [2.8%]  surface glycoprotein, V320I</title>
	<circle cx="866.9" cy="1400.2" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  G22992A  Australia=58 [81.7%]  surface glycoprotein, S477N</title>
	<circle cx="776.8" cy="1454.3" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  GGA23401AGG  Australia=3 [4.2%]  surface glycoprotein, D614G</title>
	<circle cx="698.7" cy="1501.2" r="2.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  A23403G  Australia=6 [8.5%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="1501.5" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  C23655T  Australia=2 [2.8%]  surface glycoprotein, S698L</title>
	<circle cx="650.2" cy="1530.4" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  C24351T  Australia=2 [2.8%]  surface glycoprotein, A930V</title>
	<circle cx="517.3" cy="1610.2" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  G24764T  Australia=8 [11.3%]  surface glycoprotein, V1068F</title>
	<circle cx="438.5" cy="1657.6" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  G25352T  Australia=2 [2.8%]  surface glycoprotein, V1264L</title>
	<circle cx="326.2" cy="1725.0" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27 Australia: 59 samples</title>
	<line x1="1182.7" y1="1210.0" x2="1175.7" y2="1214.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-27 New Zealand: 4 samples</title>
	<line x1="1175.7" y1="1214.0" x2="1173.0" y2="1215.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-27  G21666T  Australia=2 [3.4%]  surface glycoprotein, G35V</title>
	<circle cx="1028.1" cy="1299.2" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  T21738C  Australia=2 [3.4%]  surface glycoprotein, F59S</title>
	<circle cx="1014.3" cy="1307.2" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G22927T  Australia=2 [3.4%]  surface glycoprotein, L455F</title>
	<circle cx="784.9" cy="1439.6" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G22992A  Australia=52 [88.1%]  surface glycoprotein, S477N</title>
	<circle cx="772.4" cy="1446.9" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  GGA23401AGG  Australia=2 [3.4%]  surface glycoprotein, D614G</title>
	<circle cx="693.5" cy="1492.4" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  A23403G  New Zealand=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="1492.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  C23655T  Australia=2 [3.4%]  surface glycoprotein, S698L</title>
	<circle cx="644.5" cy="1520.7" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G24257T  Australia=2 [3.4%]  surface glycoprotein, A899S</title>
	<circle cx="528.4" cy="1587.8" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27  G24764T  Australia=12 [20.3%]  surface glycoprotein, V1068F</title>
	<circle cx="430.6" cy="1644.2" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28 Australia: 55 samples</title>
	<line x1="1182.5" y1="1209.7" x2="1175.6" y2="1213.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-28 New Zealand: 3 samples</title>
	<line x1="1175.6" y1="1213.5" x2="1173.3" y2="1214.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-28  G21666T  Australia=4 [7.3%]  surface glycoprotein, G35V</title>
	<circle cx="1026.4" cy="1296.2" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G22927T  Australia=3 [5.5%]  surface glycoprotein, L455F</title>
	<circle cx="780.8" cy="1432.4" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G22992A  Australia=51 [92.7%]  surface glycoprotein, S477N</title>
	<circle cx="768.1" cy="1439.4" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  GGA23401AGG  Australia=9 [16.4%]  surface glycoprotein, D614G</title>
	<circle cx="688.5" cy="1483.5" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="688.1" cy="1483.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  C23634T  Australia=2 [3.6%]  surface glycoprotein, S691F</title>
	<circle cx="643.1" cy="1508.7" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  C24351T  Australia=3 [5.5%]  surface glycoprotein, A930V</title>
	<circle cx="503.4" cy="1586.1" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G24764T  Australia=3 [5.5%]  surface glycoprotein, V1068F</title>
	<circle cx="423.0" cy="1630.7" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G24992C  Australia=2 [3.6%]  surface glycoprotein, E1144Q</title>
	<circle cx="378.6" cy="1655.3" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28  G25244T  Australia=2 [3.6%]  surface glycoprotein, V1228L</title>
	<circle cx="329.5" cy="1682.5" r="2.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29 Australia: 49 samples</title>
	<line x1="1182.3" y1="1209.4" x2="1175.6" y2="1213.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-29 New Zealand: 3 samples</title>
	<line x1="1175.6" y1="1213.0" x2="1173.2" y2="1214.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-29  G21604T  Australia=2 [4.1%]  surface glycoprotein, Q14H</title>
	<circle cx="1037.0" cy="1286.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  G22520A  Australia=2 [4.1%]  surface glycoprotein, V320I</title>
	<circle cx="856.8" cy="1382.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  G22992A  Australia=37 [75.5%]  surface glycoprotein, S477N</title>
	<circle cx="764.0" cy="1431.8" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  GGA23401AGG  Australia=2 [4.1%]  surface glycoprotein, D614G</title>
	<circle cx="683.6" cy="1474.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="683.2" cy="1474.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  A23403G  Australia=6 [12.2%]  surface glycoprotein, D614G</title>
	<circle cx="683.2" cy="1474.8" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  C24351T  Australia=2 [4.1%]  surface glycoprotein, A930V</title>
	<circle cx="496.8" cy="1573.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  G24764T  Australia=5 [10.2%]  surface glycoprotein, V1068F</title>
	<circle cx="415.6" cy="1617.1" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29  G24992C  Australia=2 [4.1%]  surface glycoprotein, E1144Q</title>
	<circle cx="370.7" cy="1640.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30 Australia: 31 samples</title>
	<line x1="1182.2" y1="1209.1" x2="1176.1" y2="1212.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-30  G21666T  Australia=2 [6.5%]  surface glycoprotein, G35V</title>
	<circle cx="1023.2" cy="1290.1" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30  G22927T  Australia=2 [6.5%]  surface glycoprotein, L455F</title>
	<circle cx="773.0" cy="1417.6" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30  G22992A  Australia=29 [93.5%]  surface glycoprotein, S477N</title>
	<circle cx="760.1" cy="1424.2" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30  G24764T  Australia=3 [9.7%]  surface glycoprotein, V1068F</title>
	<circle cx="408.4" cy="1603.3" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31 Australia: 56 samples</title>
	<line x1="1182.0" y1="1208.8" x2="1174.9" y2="1212.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-31  G21666T  Australia=2 [3.6%]  surface glycoprotein, G35V</title>
	<circle cx="1021.6" cy="1287.0" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  G22992A  Australia=50 [89.3%]  surface glycoprotein, S477N</title>
	<circle cx="756.2" cy="1416.5" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  GGA23401AGG  Australia=4 [7.1%]  surface glycoprotein, D614G</title>
	<circle cx="674.3" cy="1456.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  A23403G  Australia=2 [3.6%]  surface glycoprotein, D614G</title>
	<circle cx="673.9" cy="1456.6" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  C23655T  Australia=3 [5.4%]  surface glycoprotein, S698L</title>
	<circle cx="623.5" cy="1481.2" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  G24764T  Australia=7 [12.5%]  surface glycoprotein, V1068F</title>
	<circle cx="401.5" cy="1589.5" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01 Australia: 59 samples</title>
	<line x1="1181.9" y1="1208.5" x2="1174.6" y2="1211.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-01  G21666T  Australia=2 [3.4%]  surface glycoprotein, G35V</title>
	<circle cx="1020.2" cy="1283.9" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G22992A  Australia=49 [83.1%]  surface glycoprotein, S477N</title>
	<circle cx="752.5" cy="1408.7" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  GGA23401AGG  Australia=5 [8.5%]  surface glycoprotein, D614G</title>
	<circle cx="669.9" cy="1447.2" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  A23403G  Australia=6 [10.2%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="1447.4" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  C23655T  Australia=3 [5.1%]  surface glycoprotein, S698L</title>
	<circle cx="618.7" cy="1471.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G24764T  Australia=4 [6.8%]  surface glycoprotein, V1068F</title>
	<circle cx="394.8" cy="1575.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02 Australia: 41 samples</title>
	<line x1="1181.7" y1="1208.1" x2="1175.1" y2="1211.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-02  G22992A  Australia=37 [90.2%]  surface glycoprotein, S477N</title>
	<circle cx="748.9" cy="1400.8" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  GGA23401AGG  Australia=3 [7.3%]  surface glycoprotein, D614G</title>
	<circle cx="665.7" cy="1437.9" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C23655T  Australia=3 [7.3%]  surface glycoprotein, S698L</title>
	<circle cx="614.0" cy="1460.9" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  C24026T  Australia=2 [4.9%]  surface glycoprotein, L822F</title>
	<circle cx="538.5" cy="1494.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02  G24764T  Australia=7 [17.1%]  surface glycoprotein, V1068F</title>
	<circle cx="388.4" cy="1561.4" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03 Australia: 31 samples</title>
	<line x1="1181.6" y1="1207.8" x2="1175.4" y2="1210.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-03 New Zealand: 2 samples</title>
	<line x1="1175.4" y1="1210.5" x2="1173.4" y2="1211.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-03  G22992A  Australia=28 [90.3%]  surface glycoprotein, S477N</title>
	<circle cx="745.5" cy="1392.9" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  GGA23401AGG  Australia=3 [9.7%]  surface glycoprotein, D614G</title>
	<circle cx="661.6" cy="1428.5" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="1428.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03  G24764T  Australia=4 [12.9%]  surface glycoprotein, V1068F</title>
	<circle cx="382.2" cy="1547.1" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04 Australia: 39 samples</title>
	<line x1="1181.5" y1="1207.5" x2="1174.8" y2="1210.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-04  G22992A  Australia=29 [74.4%]  surface glycoprotein, S477N</title>
	<circle cx="742.2" cy="1385.0" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  GGA23401AGG  Australia=2 [5.1%]  surface glycoprotein, D614G</title>
	<circle cx="657.7" cy="1419.1" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  A23403G  Australia=2 [5.1%]  surface glycoprotein, D614G</title>
	<circle cx="657.3" cy="1419.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  G24764T  Australia=2 [5.1%]  surface glycoprotein, V1068F</title>
	<circle cx="376.3" cy="1532.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05 Australia: 28 samples</title>
	<line x1="1181.3" y1="1207.2" x2="1175.2" y2="1209.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-05  G22992A  Australia=19 [67.9%]  surface glycoprotein, S477N</title>
	<circle cx="739.0" cy="1376.9" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  A23403G  Australia=4 [14.3%]  surface glycoprotein, D614G</title>
	<circle cx="653.6" cy="1409.8" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05  G24764T  Australia=2 [7.1%]  surface glycoprotein, V1068F</title>
	<circle cx="370.6" cy="1518.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06 Australia: 33 samples</title>
	<line x1="1181.2" y1="1206.8" x2="1174.7" y2="1209.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-06  G21666T  Australia=3 [9.1%]  surface glycoprotein, G35V</title>
	<circle cx="1013.5" cy="1267.9" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  G22992A  Australia=30 [90.9%]  surface glycoprotein, S477N</title>
	<circle cx="736.0" cy="1368.9" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  GGA23401AGG  Australia=4 [12.1%]  surface glycoprotein, D614G</title>
	<circle cx="650.4" cy="1400.0" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06  G24764T  Australia=2 [6.1%]  surface glycoprotein, V1068F</title>
	<circle cx="365.2" cy="1503.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07 Australia: 39 samples</title>
	<line x1="1181.1" y1="1206.5" x2="1174.3" y2="1208.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-07  G21666T  Australia=3 [7.7%]  surface glycoprotein, G35V</title>
	<circle cx="1012.4" cy="1264.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  G22992A  Australia=30 [76.9%]  surface glycoprotein, S477N</title>
	<circle cx="733.1" cy="1360.8" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  GGA23401AGG  Australia=3 [7.7%]  surface glycoprotein, D614G</title>
	<circle cx="647.0" cy="1390.4" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  C23655T  Australia=2 [5.1%]  surface glycoprotein, S698L</title>
	<circle cx="593.5" cy="1408.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  G24764T  Australia=6 [15.4%]  surface glycoprotein, V1068F</title>
	<circle cx="360.0" cy="1489.2" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08 Australia: 27 samples</title>
	<line x1="1181.0" y1="1206.2" x2="1174.8" y2="1208.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-08  G22992A  Australia=21 [77.8%]  surface glycoprotein, S477N</title>
	<circle cx="730.4" cy="1352.6" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  A23403G  Australia=3 [11.1%]  surface glycoprotein, D614G</title>
	<circle cx="643.3" cy="1380.9" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  C23655T  Australia=2 [7.4%]  surface glycoprotein, S698L</title>
	<circle cx="590.0" cy="1398.2" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-08  G24764T  Australia=3 [11.1%]  surface glycoprotein, V1068F</title>
	<circle cx="355.1" cy="1474.5" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09 Australia: 27 samples</title>
	<line x1="1180.9" y1="1205.8" x2="1174.6" y2="1207.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-09  G22992A  Australia=25 [92.6%]  surface glycoprotein, S477N</title>
	<circle cx="727.8" cy="1344.4" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  GGA23401AGG  Australia=2 [7.4%]  surface glycoprotein, D614G</title>
	<circle cx="640.7" cy="1371.0" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  G24764T  Australia=6 [22.2%]  surface glycoprotein, V1068F</title>
	<circle cx="350.4" cy="1459.7" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10 Australia: 24 samples</title>
	<line x1="1180.8" y1="1205.5" x2="1174.7" y2="1207.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-10  G21666T  Australia=2 [8.3%]  surface glycoprotein, G35V</title>
	<circle cx="1009.2" cy="1254.7" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  G22927T  Australia=2 [8.3%]  surface glycoprotein, L455F</title>
	<circle cx="739.3" cy="1332.1" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  G22992A  Australia=17 [70.8%]  surface glycoprotein, S477N</title>
	<circle cx="725.4" cy="1336.1" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  A23403G  Australia=3 [12.5%]  surface glycoprotein, D614G</title>
	<circle cx="637.4" cy="1361.3" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  G24764T  Australia=3 [12.5%]  surface glycoprotein, V1068F</title>
	<circle cx="346.0" cy="1444.9" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11 Australia: 20 samples</title>
	<line x1="1180.7" y1="1205.2" x2="1174.9" y2="1206.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-11  G22992A  Australia=17 [85.0%]  surface glycoprotein, S477N</title>
	<circle cx="723.1" cy="1327.8" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  GGA23401AGG  Australia=4 [20.0%]  surface glycoprotein, D614G</title>
	<circle cx="635.1" cy="1351.4" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  G24764T  Australia=2 [10.0%]  surface glycoprotein, V1068F</title>
	<circle cx="341.9" cy="1429.9" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12 Australia: 19 samples</title>
	<line x1="1180.6" y1="1204.8" x2="1174.9" y2="1206.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-12  G22992A  Australia=15 [78.9%]  surface glycoprotein, S477N</title>
	<circle cx="720.9" cy="1319.5" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  GGA23401AGG  Australia=2 [10.5%]  surface glycoprotein, D614G</title>
	<circle cx="632.5" cy="1341.5" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  A23403G  Australia=2 [10.5%]  surface glycoprotein, D614G</title>
	<circle cx="632.1" cy="1341.6" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  C23655T  Australia=2 [10.5%]  surface glycoprotein, S698L</title>
	<circle cx="577.6" cy="1355.2" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12  G24764T  Australia=2 [10.5%]  surface glycoprotein, V1068F</title>
	<circle cx="338.0" cy="1414.9" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13 Australia: 26 samples</title>
	<line x1="1180.5" y1="1204.5" x2="1174.2" y2="1205.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-13 New Zealand: 2 samples</title>
	<line x1="1174.2" y1="1205.9" x2="1172.1" y2="1206.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-13  C21575T  Australia=2 [7.7%]  surface glycoprotein, L5F</title>
	<circle cx="1026.4" cy="1240.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  G22335T  New Zealand=2 [100.0%]  surface glycoprotein, W258L</title>
	<circle cx="861.5" cy="1278.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  G22992A  Australia=20 [76.9%]  surface glycoprotein, S477N</title>
	<circle cx="718.9" cy="1311.1" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  GGA23401AGG  Australia=2 [7.7%]  surface glycoprotein, D614G</title>
	<circle cx="630.1" cy="1331.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="629.7" cy="1331.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  A23403G  Australia=3 [11.5%]  surface glycoprotein, D614G</title>
	<circle cx="629.7" cy="1331.7" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  G24764T  Australia=2 [7.7%]  surface glycoprotein, V1068F</title>
	<circle cx="334.4" cy="1399.9" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14 Australia: 28 samples</title>
	<line x1="1180.4" y1="1204.2" x2="1174.0" y2="1205.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-14  G22992A  Australia=27 [96.4%]  surface glycoprotein, S477N</title>
	<circle cx="717.0" cy="1302.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  GGA23401AGG  Australia=6 [21.4%]  surface glycoprotein, D614G</title>
	<circle cx="627.9" cy="1321.6" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  G24764T  Australia=2 [7.1%]  surface glycoprotein, V1068F</title>
	<circle cx="331.0" cy="1384.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15 Australia: 23 samples</title>
	<line x1="1180.4" y1="1203.8" x2="1174.3" y2="1205.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-15  C21597T  Australia=2 [8.7%]  surface glycoprotein, S12F</title>
	<circle cx="1020.3" cy="1234.9" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  G22927T  Australia=2 [8.7%]  surface glycoprotein, L455F</title>
	<circle cx="729.5" cy="1291.5" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  G22992A  Australia=18 [78.3%]  surface glycoprotein, S477N</title>
	<circle cx="715.3" cy="1294.2" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  A23403G  Australia=5 [21.7%]  surface glycoprotein, D614G</title>
	<circle cx="625.5" cy="1311.7" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  G24236T  Australia=2 [8.7%]  surface glycoprotein, A892S</title>
	<circle cx="443.3" cy="1347.1" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  G24764T  Australia=5 [21.7%]  surface glycoprotein, V1068F</title>
	<circle cx="327.9" cy="1369.5" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16 Australia: 25 samples</title>
	<line x1="1180.3" y1="1203.5" x2="1174.0" y2="1204.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-16  G22992A  Australia=25 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="713.7" cy="1285.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  GGA23401AGG  Australia=6 [24.0%]  surface glycoprotein, D614G</title>
	<circle cx="624.0" cy="1301.6" r="5.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17 Australia: 16 samples</title>
	<line x1="1180.2" y1="1203.1" x2="1174.8" y2="1204.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-17  G22992A  Australia=12 [75.0%]  surface glycoprotein, S477N</title>
	<circle cx="712.3" cy="1277.2" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  GGA23401AGG  Australia=2 [12.5%]  surface glycoprotein, D614G</title>
	<circle cx="622.3" cy="1291.5" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  A23403G  Australia=4 [25.0%]  surface glycoprotein, D614G</title>
	<circle cx="621.9" cy="1291.6" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17  G24764T  Australia=2 [12.5%]  surface glycoprotein, V1068F</title>
	<circle cx="322.5" cy="1339.0" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18 Australia: 15 samples</title>
	<line x1="1180.2" y1="1202.8" x2="1174.8" y2="1203.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-18  G22992A  Australia=14 [93.3%]  surface glycoprotein, S477N</title>
	<circle cx="711.0" cy="1268.7" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19 Australia: 14 samples</title>
	<line x1="1180.1" y1="1202.4" x2="1174.9" y2="1203.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-19 New Zealand: 2 samples</title>
	<line x1="1174.9" y1="1203.1" x2="1172.8" y2="1203.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-19  G21785C  New Zealand=2 [100.0%]  surface glycoprotein, G75R</title>
	<circle cx="976.7" cy="1227.4" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19  C22227T  Australia=2 [14.3%]  surface glycoprotein, A222V</title>
	<circle cx="879.0" cy="1239.4" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19  G22992A  Australia=13 [92.9%]  surface glycoprotein, S477N</title>
	<circle cx="709.9" cy="1260.2" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19  GGA23401AGG  Australia=2 [14.3%]  surface glycoprotein, D614G</title>
	<circle cx="619.5" cy="1271.3" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-19  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="619.1" cy="1271.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-20 Australia: 10 samples</title>
	<line x1="1180.1" y1="1202.1" x2="1175.4" y2="1202.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-20  G22992A  Australia=9 [90.0%]  surface glycoprotein, S477N</title>
	<circle cx="708.9" cy="1251.6" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21 Australia: 3 samples</title>
	<line x1="1180.1" y1="1201.7" x2="1177.4" y2="1202.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-21 New Zealand: 3 samples</title>
	<line x1="1177.4" y1="1202.0" x2="1174.7" y2="1202.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-21  G21785C  New Zealand=2 [66.7%]  surface glycoprotein, G75R</title>
	<circle cx="975.9" cy="1219.6" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  G22992A  Australia=2 [66.7%]  surface glycoprotein, S477N</title>
	<circle cx="708.1" cy="1243.0" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-21  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.9" cy="1251.0" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22 Australia: 8 samples</title>
	<line x1="1180.0" y1="1201.4" x2="1175.8" y2="1201.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-22  G22992A  Australia=8 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="707.4" cy="1234.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  GGA23401AGG  Australia=2 [25.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.6" cy="1240.8" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23 Australia: 10 samples</title>
	<line x1="1180.0" y1="1201.0" x2="1175.3" y2="1201.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-23  G22992A  Australia=7 [70.0%]  surface glycoprotein, S477N</title>
	<circle cx="706.9" cy="1225.8" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  A23403G  Australia=2 [20.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.5" cy="1230.6" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24 Australia: 8 samples</title>
	<line x1="1180.0" y1="1200.7" x2="1175.7" y2="1200.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-24  G22992A  Australia=5 [62.5%]  surface glycoprotein, S477N</title>
	<circle cx="706.5" cy="1217.2" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25 Australia: 7 samples</title>
	<line x1="1180.0" y1="1200.3" x2="1175.9" y2="1200.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-25  C21597T  Australia=4 [57.1%]  surface glycoprotein, S12F</title>
	<circle cx="1017.0" cy="1203.2" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  G22992A  Australia=2 [28.6%]  surface glycoprotein, S477N</title>
	<circle cx="706.3" cy="1208.6" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  A23403G  Australia=4 [57.1%]  surface glycoprotein, D614G</title>
	<circle cx="614.8" cy="1210.2" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  G23522A  Australia=4 [57.1%]  surface glycoprotein, E654K</title>
	<circle cx="588.3" cy="1210.7" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25  C25487T  Australia=4 [57.1%]  ORF3a protein, T32I</title>
	<circle cx="150.7" cy="1218.3" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26 Australia: 6 samples</title>
	<line x1="1180.0" y1="1200.0" x2="1176.2" y2="1200.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-26  C21597T  Australia=3 [50.0%]  surface glycoprotein, S12F</title>
	<circle cx="1016.9" cy="1200.0" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  G22992A  Australia=3 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="706.2" cy="1200.0" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  A23403G  Australia=3 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="614.7" cy="1200.0" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  G23522A  Australia=3 [50.0%]  surface glycoprotein, E654K</title>
	<circle cx="588.2" cy="1200.0" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26  C25487T  Australia=3 [50.0%]  ORF3a protein, T32I</title>
	<circle cx="150.6" cy="1200.0" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-27 Australia: 4 samples</title>
	<line x1="1180.0" y1="1199.7" x2="1176.9" y2="1199.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-27  G22992A  Australia=4 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="706.3" cy="1191.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28 Australia: 3 samples</title>
	<line x1="1180.0" y1="1199.3" x2="1177.3" y2="1199.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-28  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.1" cy="1179.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29 Australia: 3 samples</title>
	<line x1="1180.0" y1="1199.0" x2="1177.3" y2="1198.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-29 New Zealand: 2 samples</title>
	<line x1="1177.3" y1="1198.8" x2="1175.2" y2="1198.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-29  G22992A  Australia=2 [66.7%]  surface glycoprotein, S477N</title>
	<circle cx="706.9" cy="1174.2" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.5" cy="1169.4" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30 Australia: 2 samples</title>
	<line x1="1180.0" y1="1198.6" x2="1177.9" y2="1198.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-02 Australia: 2 samples</title>
	<line x1="1180.1" y1="1197.9" x2="1178.0" y2="1197.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-02 New Zealand: 2 samples</title>
	<line x1="1178.0" y1="1197.7" x2="1175.8" y2="1197.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-02  C22227T  New Zealand=2 [100.0%]  surface glycoprotein, A222V</title>
	<circle cx="878.4" cy="1166.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-02  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="617.9" cy="1138.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03 Australia: 6 samples</title>
	<line x1="1180.1" y1="1197.6" x2="1176.4" y2="1197.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-03  G22992A  Australia=4 [66.7%]  surface glycoprotein, S477N</title>
	<circle cx="709.9" cy="1139.8" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03  A23403G  Australia=2 [33.3%]  surface glycoprotein, D614G</title>
	<circle cx="619.1" cy="1128.7" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04 Australia: 4 samples</title>
	<line x1="1180.2" y1="1197.2" x2="1177.1" y2="1196.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-04 New Zealand: 2 samples</title>
	<line x1="1177.1" y1="1196.8" x2="1175.0" y2="1196.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-04  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="620.4" cy="1118.5" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04  A23403G  Australia=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="620.4" cy="1118.5" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05 Australia: 2 samples</title>
	<line x1="1180.2" y1="1196.9" x2="1178.1" y2="1196.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-05  G22992A  Australia=2 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="712.3" cy="1122.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06 Australia: 6 samples</title>
	<line x1="1180.3" y1="1196.5" x2="1176.6" y2="1195.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-06 New Zealand: 2 samples</title>
	<line x1="1176.6" y1="1195.9" x2="1174.4" y2="1195.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-06 Papua New Guinea: 2 samples</title>
	<line x1="1174.4" y1="1195.5" x2="1172.3" y2="1195.1" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-06  G22992A  Australia=3 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="713.7" cy="1114.3" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="623.6" cy="1098.4" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  A23403G  Australia=3 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="623.6" cy="1098.4" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06  G24764T  Australia=2 [33.3%]  surface glycoprotein, V1068F</title>
	<circle cx="325.1" cy="1045.7" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07 Australia: 8 samples</title>
	<line x1="1180.4" y1="1196.2" x2="1176.2" y2="1195.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-07  C22383T  Australia=4 [50.0%]  surface glycoprotein, T274I</title>
	<circle cx="848.5" cy="1131.7" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  G22992A  Australia=6 [75.0%]  surface glycoprotein, S477N</title>
	<circle cx="715.3" cy="1105.8" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  A23403G  Australia=2 [25.0%]  surface glycoprotein, D614G</title>
	<circle cx="625.5" cy="1088.3" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07  G24764T  Australia=5 [62.5%]  surface glycoprotein, V1068F</title>
	<circle cx="327.9" cy="1030.5" r="7.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08 Australia: 5 samples</title>
	<line x1="1180.4" y1="1195.8" x2="1177.0" y2="1195.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-08 New Zealand: 2 samples</title>
	<line x1="1177.0" y1="1195.1" x2="1174.9" y2="1194.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-08  C22227T  New Zealand=2 [100.0%]  surface glycoprotein, A222V</title>
	<circle cx="883.7" cy="1132.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G22992A  Australia=5 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="717.0" cy="1097.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="627.5" cy="1078.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08  G24764T  Australia=3 [60.0%]  surface glycoprotein, V1068F</title>
	<circle cx="331.0" cy="1015.3" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09 Australia: 4 samples</title>
	<line x1="1180.5" y1="1195.5" x2="1177.4" y2="1194.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-09  G22992A  Australia=2 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="718.9" cy="1088.9" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  GGA23401AGG  Australia=2 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="630.1" cy="1068.4" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  A23403G  Australia=2 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="629.7" cy="1068.3" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10 Australia: 3 samples</title>
	<line x1="1180.6" y1="1195.2" x2="1178.0" y2="1194.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-10  C21575T  Australia=2 [66.7%]  surface glycoprotein, L5F</title>
	<circle cx="1027.1" cy="1156.9" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10  A23403G  Australia=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="632.1" cy="1058.4" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11 Australia: 9 samples</title>
	<line x1="1180.7" y1="1194.8" x2="1176.3" y2="1193.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-11  C21575T  Australia=2 [22.2%]  surface glycoprotein, L5F</title>
	<circle cx="1027.9" cy="1153.9" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11  ATTA22190A  Australia=2 [22.2%]  surface glycoprotein, I210N</title>
	<circle cx="895.6" cy="1118.4" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11  G22992A  Australia=5 [55.6%]  surface glycoprotein, S477N</title>
	<circle cx="723.1" cy="1072.2" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11  A23403G  Australia=5 [55.6%]  surface glycoprotein, D614G</title>
	<circle cx="634.6" cy="1048.5" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11  G24764T  Australia=4 [44.4%]  surface glycoprotein, V1068F</title>
	<circle cx="341.9" cy="970.1" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12 Australia: 10 samples</title>
	<line x1="1180.8" y1="1194.5" x2="1176.3" y2="1193.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-12  C22120A  Australia=5 [50.0%]  surface glycoprotein, F186L</title>
	<circle cx="912.0" cy="1117.4" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G22992A  Australia=7 [70.0%]  surface glycoprotein, S477N</title>
	<circle cx="725.4" cy="1063.9" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  A23403G  Australia=3 [30.0%]  surface glycoprotein, D614G</title>
	<circle cx="637.4" cy="1038.7" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G24764T  Australia=6 [60.0%]  surface glycoprotein, V1068F</title>
	<circle cx="346.0" cy="955.1" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13 Australia: 4 samples</title>
	<line x1="1180.9" y1="1194.2" x2="1177.9" y2="1193.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-13  G22992A  Australia=3 [75.0%]  surface glycoprotein, S477N</title>
	<circle cx="727.8" cy="1055.6" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14 Australia: 3 samples</title>
	<line x1="1181.0" y1="1193.8" x2="1178.4" y2="1193.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-14  G22992A  Australia=3 [100.0%]  surface glycoprotein, S477N</title>
	<circle cx="730.4" cy="1047.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  G24764T  Australia=2 [66.7%]  surface glycoprotein, V1068F</title>
	<circle cx="355.1" cy="925.5" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15 Australia: 3 samples</title>
	<line x1="1181.1" y1="1193.5" x2="1178.5" y2="1192.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-15  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="646.6" cy="1009.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16 Australia: 3 samples</title>
	<line x1="1181.2" y1="1193.2" x2="1178.7" y2="1192.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-16  G23236T  Australia=2 [66.7%]  surface glycoprotein, K558N</title>
	<circle cx="684.9" cy="1012.5" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="650.0" cy="999.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-17 Australia: 2 samples</title>
	<line x1="1181.3" y1="1192.8" x2="1179.3" y2="1192.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-17  C21575T  Australia=2 [100.0%]  surface glycoprotein, L5F</title>
	<circle cx="1033.7" cy="1136.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18 Australia: 8 samples</title>
	<line x1="1181.5" y1="1192.5" x2="1177.5" y2="1190.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-18  G22343C  Australia=7 [87.5%]  surface glycoprotein, G261R</title>
	<circle cx="876.2" cy="1069.2" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  A23403G  Australia=7 [87.5%]  surface glycoprotein, D614G</title>
	<circle cx="657.3" cy="980.7" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  C23664T  Australia=7 [87.5%]  surface glycoprotein, A701V</title>
	<circle cx="603.4" cy="959.0" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20 Australia: 3 samples</title>
	<line x1="1181.7" y1="1191.9" x2="1179.3" y2="1190.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-20  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="665.3" cy="961.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21 Australia: 5 samples</title>
	<line x1="1181.9" y1="1191.5" x2="1178.7" y2="1190.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-21  C22227T  Australia=2 [40.0%]  surface glycoprotein, A222V</title>
	<circle cx="906.9" cy="1063.3" r="6.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21  A23403G  Australia=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="952.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22 Australia: 5 samples</title>
	<line x1="1182.0" y1="1191.2" x2="1178.9" y2="1189.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-22 New Zealand: 8 samples</title>
	<line x1="1178.9" y1="1189.7" x2="1175.0" y2="1187.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-22  A23403G  New Zealand=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="673.9" cy="943.4" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  A23403G  Australia=4 [80.0%]  surface glycoprotein, D614G</title>
	<circle cx="673.9" cy="943.4" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  C23457T  New Zealand=2 [25.0%]  surface glycoprotein, T632I</title>
	<circle cx="663.1" cy="938.1" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  C23604G  New Zealand=2 [25.0%]  surface glycoprotein, P681R</title>
	<circle cx="633.7" cy="923.8" r="5.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23 Australia: 2 samples</title>
	<line x1="1182.2" y1="1190.9" x2="1180.3" y2="1189.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-23  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="678.5" cy="934.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24 Australia: 6 samples</title>
	<line x1="1182.3" y1="1190.6" x2="1179.0" y2="1188.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-24  A23403G  Australia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="683.2" cy="925.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24  G24926T  Australia=2 [33.3%]  surface glycoprotein, V1122L</title>
	<circle cx="383.7" cy="766.0" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25 Australia: 2 samples</title>
	<line x1="1182.5" y1="1190.3" x2="1180.6" y2="1189.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-25 New Zealand: 4 samples</title>
	<line x1="1180.6" y1="1189.3" x2="1177.9" y2="1187.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-25  A23403G  New Zealand=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="688.1" cy="916.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  C23457T  New Zealand=2 [50.0%]  surface glycoprotein, T632I</title>
	<circle cx="677.6" cy="910.4" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25  C23604G  New Zealand=2 [50.0%]  surface glycoprotein, P681R</title>
	<circle cx="648.9" cy="894.5" r="6.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26 Australia: 4 samples</title>
	<line x1="1182.7" y1="1190.0" x2="1180.0" y2="1188.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-26 New Zealand: 3 samples</title>
	<line x1="1180.0" y1="1188.4" x2="1177.6" y2="1187.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-26  G22992A  Australia=2 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="772.4" cy="953.1" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="907.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A23403G  Australia=4 [100.0%] New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="907.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G25049T  New Zealand=2 [66.7%]  surface glycoprotein, D1163Y</title>
	<circle cx="375.6" cy="724.1" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27 Australia: 4 samples</title>
	<line x1="1182.9" y1="1189.7" x2="1180.2" y2="1188.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-27  A23403G  Australia=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="898.5" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29 Australia: 5 samples</title>
	<line x1="1183.2" y1="1189.1" x2="1180.3" y2="1187.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-29 New Zealand: 3 samples</title>
	<line x1="1180.3" y1="1187.2" x2="1178.0" y2="1185.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-29  A23403G  Australia=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="881.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  A23403G  Australia=5 [100.0%] New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="881.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30 Australia: 6 samples</title>
	<line x1="1183.4" y1="1188.8" x2="1180.3" y2="1186.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-30 New Zealand: 3 samples</title>
	<line x1="1180.3" y1="1186.7" x2="1178.0" y2="1185.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-30  G22992A  Australia=4 [66.7%]  surface glycoprotein, S477N</title>
	<circle cx="790.7" cy="923.9" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="714.8" cy="872.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30  A23403G  Australia=5 [83.3%]  surface glycoprotein, D614G</title>
	<circle cx="714.8" cy="872.7" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31 Australia: 3 samples</title>
	<line x1="1183.6" y1="1188.5" x2="1181.4" y2="1187.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-31 New Zealand: 3 samples</title>
	<line x1="1181.4" y1="1187.0" x2="1179.2" y2="1185.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-31  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="864.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31  A23403G  Australia=3 [100.0%] New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="864.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01 Australia: 2 samples</title>
	<line x1="1183.8" y1="1188.2" x2="1182.1" y2="1187.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-01 New Zealand: 2 samples</title>
	<line x1="1182.1" y1="1187.0" x2="1180.3" y2="1185.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-01  C22227T  Australia=2 [100.0%]  surface glycoprotein, A222V</title>
	<circle cx="938.4" cy="1009.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="856.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01  A23403G  Australia=2 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="856.0" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01  G23587T  Australia=2 [100.0%]  surface glycoprotein, Q675H</title>
	<circle cx="693.3" cy="831.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02 Australia: 6 samples</title>
	<line x1="1184.0" y1="1188.0" x2="1181.0" y2="1185.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-02  C21855T  Australia=2 [33.3%]  surface glycoprotein, S98F</title>
	<circle cx="1007.9" cy="1055.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G22992A  Australia=3 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="805.7" cy="902.8" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A23403G  Australia=3 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="847.8" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G24764T  Australia=3 [50.0%]  surface glycoprotein, V1068F</title>
	<circle cx="490.5" cy="665.3" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03 Australia: 2 samples</title>
	<line x1="1184.2" y1="1187.7" x2="1182.5" y2="1186.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-03 New Zealand: 2 samples</title>
	<line x1="1182.5" y1="1186.4" x2="1180.9" y2="1185.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-03  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="839.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  A23403G  Australia=2 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="839.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  T23599G  Australia=2 [100.0%]  surface glycoprotein, N679K</title>
	<circle cx="704.4" cy="812.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06 Australia: 3 samples</title>
	<line x1="1184.9" y1="1186.9" x2="1182.9" y2="1185.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-06 New Zealand: 2 samples</title>
	<line x1="1182.9" y1="1185.1" x2="1181.2" y2="1183.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-06  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="816.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A23403G  Australia=3 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="816.0" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-07 Australia: 2 samples</title>
	<line x1="1185.1" y1="1186.6" x2="1183.5" y2="1185.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-07  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="765.0" cy="808.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08 Australia: 9 samples</title>
	<line x1="1185.4" y1="1186.4" x2="1182.1" y2="1183.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-08  G23120T  Australia=2 [22.2%]  surface glycoprotein, A520S</title>
	<circle cx="818.0" cy="843.8" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  A23403G  Australia=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="800.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12 Australia: 3 samples</title>
	<line x1="1186.4" y1="1185.4" x2="1184.5" y2="1183.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-12  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="800.8" cy="771.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13 Australia: 2 samples</title>
	<line x1="1186.6" y1="1185.1" x2="1185.2" y2="1183.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-13  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="808.4" cy="765.0" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14 Australia: 3 samples</title>
	<line x1="1186.9" y1="1184.9" x2="1185.1" y2="1182.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-14  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="758.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16 Australia: 13 samples</title>
	<line x1="1187.4" y1="1184.5" x2="1184.2" y2="1180.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-16  A23403G  Australia=13 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="745.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17 Australia: 3 samples</title>
	<line x1="1187.7" y1="1184.2" x2="1186.0" y2="1182.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-17 New Zealand: 2 samples</title>
	<line x1="1186.0" y1="1182.1" x2="1184.7" y2="1180.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-17  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="839.7" cy="738.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17  A23403G  Australia=3 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="839.7" cy="738.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18 New Zealand: 2 samples</title>
	<line x1="1188.0" y1="1184.0" x2="1186.7" y2="1182.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-18  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="732.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19 Australia: 4 samples</title>
	<line x1="1188.2" y1="1183.8" x2="1186.4" y2="1181.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-19  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="726.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20 Australia: 4 samples</title>
	<line x1="1188.5" y1="1183.6" x2="1186.7" y2="1181.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-20 New Zealand: 2 samples</title>
	<line x1="1186.7" y1="1181.0" x2="1185.5" y2="1179.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-20  ATTA22190A  Australia=2 [50.0%]  surface glycoprotein, I210N</title>
	<circle cx="1019.2" cy="941.8" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A23403G  Australia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="864.3" cy="720.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A23403G  Australia=4 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="864.3" cy="720.5" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21 New Zealand: 2 samples</title>
	<line x1="1188.8" y1="1183.4" x2="1187.6" y2="1181.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-21  C21707T  New Zealand=2 [100.0%]  surface glycoprotein, H49Y</title>
	<circle cx="1083.9" cy="1027.9" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  C22314A  New Zealand=2 [100.0%]  surface glycoprotein, P251H</title>
	<circle cx="1008.3" cy="915.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="872.7" cy="714.8" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-21  C23604G  New Zealand=2 [100.0%]  surface glycoprotein, P681R</title>
	<circle cx="847.7" cy="677.7" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24 Australia: 2 samples</title>
	<line x1="1189.7" y1="1182.9" x2="1188.6" y2="1181.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-24  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="698.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G23587C  Australia=2 [100.0%]  surface glycoprotein, Q675H</title>
	<circle cx="877.4" cy="663.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C25433T  Australia=2 [100.0%]  ORF3a protein, T14I</title>
	<circle cx="665.7" cy="310.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25 New Zealand: 3 samples</title>
	<line x1="1190.0" y1="1182.7" x2="1188.6" y2="1180.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-25  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="907.3" cy="693.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A23586G  New Zealand=2 [66.7%]  surface glycoprotein, Q675R</title>
	<circle cx="887.0" cy="657.8" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26 New Zealand: 3 samples</title>
	<line x1="1190.3" y1="1182.5" x2="1189.0" y2="1180.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-26  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="688.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-27 New Zealand: 2 samples</title>
	<line x1="1190.6" y1="1182.3" x2="1189.6" y2="1180.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-27  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="925.2" cy="683.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28 Australia: 2 samples</title>
	<line x1="1190.9" y1="1182.2" x2="1189.9" y2="1180.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-28 New Zealand: 3 samples</title>
	<line x1="1189.9" y1="1180.3" x2="1188.7" y2="1177.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-28  C22879A  Australia=2 [100.0%]  surface glycoprotein, N439K</title>
	<circle cx="987.3" cy="782.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="934.3" cy="678.5" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  A23403G  New Zealand=3 [100.0%] Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="934.3" cy="678.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  G23593T  Australia=2 [100.0%]  surface glycoprotein, Q677H</title>
	<circle cx="915.1" cy="640.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  C23604A  New Zealand=2 [66.7%]  surface glycoprotein, P681H</title>
	<circle cx="914.0" cy="638.6" r="7.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-28  G25352T  Australia=2 [100.0%]  surface glycoprotein, V1264L</title>
	<circle cx="737.2" cy="291.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-29 Australia: 3 samples</title>
	<line x1="1191.2" y1="1182.0" x2="1190.0" y2="1179.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-29  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="673.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-30 Australia: 3 samples</title>
	<line x1="1191.5" y1="1181.9" x2="1190.4" y2="1179.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-30  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="952.6" cy="669.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-01 Australia: 5 samples</title>
	<line x1="1191.9" y1="1181.7" x2="1190.4" y2="1178.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-01  A23403G  Australia=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="961.9" cy="665.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-02 New Zealand: 2 samples</title>
	<line x1="1192.2" y1="1181.6" x2="1191.3" y2="1179.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-02  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="661.2" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03 New Zealand: 6 samples</title>
	<line x1="1192.5" y1="1181.5" x2="1191.1" y2="1177.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-03  A23403G  New Zealand=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="657.3" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-04 Australia: 2 samples</title>
	<line x1="1192.8" y1="1181.3" x2="1192.1" y2="1179.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-04  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="990.2" cy="653.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-06 New Zealand: 2 samples</title>
	<line x1="1193.5" y1="1181.1" x2="1192.8" y2="1179.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-06  A23403G  New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1009.4" cy="646.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08 Australia: 6 samples</title>
	<line x1="1194.2" y1="1180.9" x2="1193.0" y2="1177.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-08  G21600T  Australia=2 [33.3%]  surface glycoprotein, S13I</title>
	<circle cx="1146.3" cy="1024.3" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  C21638T  Australia=2 [33.3%]  surface glycoprotein, P26S</title>
	<circle cx="1143.8" cy="1016.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G22018T  Australia=2 [33.3%]  surface glycoprotein, W152C</title>
	<circle cx="1119.1" cy="935.3" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G22021T  Australia=2 [33.3%]  surface glycoprotein, M153I</title>
	<circle cx="1118.9" cy="934.6" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  T22917G  Australia=2 [33.3%]  surface glycoprotein, L452R</title>
	<circle cx="1060.5" cy="743.8" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  A23403G  Australia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="640.3" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-08  G25455T  Australia=2 [33.3%]  ORF3a protein, K21N</title>
	<circle cx="895.3" cy="203.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09 Australia: 2 samples</title>
	<line x1="1194.5" y1="1180.8" x2="1193.9" y2="1178.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-09 New Zealand: 3 samples</title>
	<line x1="1193.9" y1="1178.7" x2="1193.1" y2="1176.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-09  A23403G  New Zealand=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="637.4" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-09  A23403G  New Zealand=3 [100.0%] Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="637.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-10 Australia: 2 samples</title>
	<line x1="1194.8" y1="1180.7" x2="1194.3" y2="1178.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-10  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1048.5" cy="634.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11 Australia: 2 samples</title>
	<line x1="1195.2" y1="1180.6" x2="1194.6" y2="1178.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-11 New Zealand: 2 samples</title>
	<line x1="1194.6" y1="1178.5" x2="1194.1" y2="1176.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-11  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1058.4" cy="632.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  A23403G  Australia=2 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1058.4" cy="632.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-11  A23592C  Australia=2 [100.0%]  surface glycoprotein, Q677P</title>
	<circle cx="1048.2" cy="591.2" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-12 Australia: 2 samples</title>
	<line x1="1195.5" y1="1180.5" x2="1195.0" y2="1178.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-12  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1068.3" cy="629.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14 Australia: 7 samples</title>
	<line x1="1196.2" y1="1180.4" x2="1195.4" y2="1176.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-14  C21627T  Australia=2 [28.6%]  surface glycoprotein, T22I</title>
	<circle cx="1163.8" cy="1013.7" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  A23403G  Australia=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1088.3" cy="625.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  G23624T  Australia=2 [28.6%]  surface glycoprotein, A688S</title>
	<circle cx="1078.9" cy="577.1" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C24138T  Australia=2 [28.6%]  surface glycoprotein, T859I</title>
	<circle cx="1057.1" cy="464.8" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C24912T  Australia=2 [28.6%]  surface glycoprotein, T1117I</title>
	<circle cx="1024.2" cy="295.5" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14  C25427T  Australia=2 [28.6%]  ORF3a protein, T12I</title>
	<circle cx="1002.3" cy="183.0" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15 Australia: 3 samples</title>
	<line x1="1196.5" y1="1180.3" x2="1196.1" y2="1177.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-15 New Zealand: 2 samples</title>
	<line x1="1196.1" y1="1177.6" x2="1195.7" y2="1175.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-15  C22227T  New Zealand=2 [100.0%]  surface glycoprotein, A222V</title>
	<circle cx="1143.8" cy="881.5" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  A23403G  Australia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="623.6" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15  A23403G  Australia=3 [100.0%] New Zealand=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="623.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16 Australia: 15 samples</title>
	<line x1="1196.9" y1="1180.2" x2="1196.0" y2="1174.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-16  A23064C  Australia=11 [73.3%]  surface glycoprotein, N501T</title>
	<circle cx="1120.2" cy="696.5" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-16  A23403G  Australia=15 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1108.4" cy="621.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17 Australia: 22 samples</title>
	<line x1="1197.2" y1="1180.2" x2="1196.4" y2="1174.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-17  A23064C  Australia=19 [86.4%]  surface glycoprotein, N501T</title>
	<circle cx="1129.0" cy="695.2" r="7.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-17  A23403G  Australia=22 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1118.5" cy="620.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18 Australia: 17 samples</title>
	<line x1="1197.6" y1="1180.1" x2="1196.9" y2="1174.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-18  A23064C  Australia=16 [94.1%]  surface glycoprotein, N501T</title>
	<circle cx="1137.9" cy="694.0" r="7.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-18  A23403G  Australia=17 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1128.7" cy="619.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19 Australia: 9 samples</title>
	<line x1="1197.9" y1="1180.1" x2="1197.4" y2="1175.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-19  A23064C  Australia=4 [44.4%]  surface glycoprotein, N501T</title>
	<circle cx="1146.7" cy="693.0" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-19  A23403G  Australia=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="617.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20 Australia: 7 samples</title>
	<line x1="1198.3" y1="1180.1" x2="1197.9" y2="1176.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-20  A23064C  Australia=4 [57.1%]  surface glycoprotein, N501T</title>
	<circle cx="1155.6" cy="692.1" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-20  A23403G  Australia=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1149.0" cy="616.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21 Australia: 7 samples</title>
	<line x1="1198.6" y1="1180.0" x2="1198.3" y2="1176.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-21  A23064C  Australia=4 [57.1%]  surface glycoprotein, N501T</title>
	<circle cx="1164.4" cy="691.4" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21  A23403G  Australia=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="616.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-22 Australia: 2 samples</title>
	<line x1="1199.0" y1="1180.0" x2="1198.8" y2="1177.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-22  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1169.4" cy="615.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23 Australia: 2 samples</title>
	<line x1="1199.3" y1="1180.0" x2="1199.2" y2="1177.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-23  A23064C  Australia=2 [100.0%]  surface glycoprotein, N501T</title>
	<circle cx="1182.2" cy="690.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-23  A23403G  Australia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="615.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24 Australia: 6 samples</title>
	<line x1="1199.7" y1="1180.0" x2="1199.6" y2="1176.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-24  A23064C  Australia=5 [83.3%]  surface glycoprotein, N501T</title>
	<circle cx="1191.1" cy="690.3" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-24  A23403G  Australia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="614.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-25 Australia: 8 samples</title>
	<line x1="1200.0" y1="1180.0" x2="1200.0" y2="1175.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-25  A23064C  Australia=6 [75.0%]  surface glycoprotein, N501T</title>
	<circle cx="1200.0" cy="690.2" r="7.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-25  A23403G  Australia=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1200.0" cy="614.7" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<rect x="1865" y="140" width="500" height="135" rx="15" style="fill:gainsboro;stroke-width:0;fill-opacity:0.15;" />
<text font-size="1.8em" x="1880" y="170" fill="white">Data from 4 countries in Oceania</text>
<text font-size="1.8em" x="1880" y="200" fill="white">Genomes/year10  Genomes/day2</text>
<text font-size="1.8em" x="1880" y="230" fill="white">103 distinct missense variants mapped</text>
<text font-size="1.8em" x="1880" y="260" fill="white">Updated 2021-01-21</text>
</svg>
